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Developmental programming of health and disease correlates the adverse 
intrauterine environment and the risk of disease later in life as cardiovascular disease, 
metabolic diseases, renal dysfunction or neurobehavioral disorders among others. 
Maternal hypoxia is one of the most common intrauterine growth restricted environment 
during pregnancy.  Perinatal hypoxic-ischemic encephalopathy is an important cause of 
brain injury in the newborn due to a systematic asphyxia. Our study aims to test the 
hypothesis that maternal hypoxia affect the organogenesis of the kidney by affecting the 
kidney structure and focusing on the roles of AT1R and AT2R, while the brain 
development will also be affected by this maternal insult increasing the vulnerability of 
this to HIE brain injury and the role of GR and the epigenetic modification that regulate 
the expression of the GR will be assessed. Finally, the MAPK/ERK pathway as part of 
the downstream of the neuroprotective mechanism of the GR against neonate HIE brain 
injury will be evaluated. To address these issues two rats model were established: 
perinatal hypoxia exposure model in time-dated pregnant rats and hypoxic-ischemic 
encephalopathy in 10-day-old rat pups.  Through these studies we found that maternal 
hypoxia decrease the number of glomeruli in offspring rat kidneys and a down-regulation 
on the expression of AT1R was observed in the kidneys of the adult rats in a sex 
xvi 
dimorphism way, affecting more the females than the males. In addition, we observed 
that maternal hypoxia increased the vulnerability of the brain to HIE on P-10 pups by 
repressing the expression of GR.  Epigenetics studies demonstrated that this down-
regulation of GR was due to hypermethylation on promoter region of exon variants 17 
and 111 of the GR gene. Dexamethasone, a synthetic glucocorticoid, treatment on 
normoxic P-10 brains increased the expression of LPGDS, and pERK44 and also the 
level of prostaglandin D2, while, the neuroprotective effect of dexamethasone observed 
against HIE brain injury on P-10 pups was diminished by MAPK/ERK and LPGDS 
inhibitor, and by blocking the DP1 receptor. These findings provide a new insight in 
understanding the pathogenesis of HIE in newborns and may suggest potential targets for 
the prevention and treatment of HIE brain injury. 
 
 
1 
 
 
CHAPTER ONE 
INTRODUCTION 
 
Programing Diseases 
Adverse fetal environment, mostly manifested as intrauterine growth restriction 
(IUGR), contribute to affect organogenesis and furthermore, may affect organ function at 
maturity increasing the probability for an individual to have a variety of health problems 
such as coronary heart disease, type 2 diabetes, neurobehavioral disorders, hypertension, 
cardiovascular disease, or renal dysfunction among others (Dudley, Li, Kobor, Kippin, & 
Bredy, 2011; Harris & Seckl, 2011). This adverse insult during fetal development may 
lead to low birth weight, which is a common marker of IUGR in the offspring. The 
hypothesis of ‘‘developmental programming of health and disease’’ or ‘‘fetal origins of 
adult disease’’ was put forward to elucidate these links between adverse intrauterine 
environment, fetal growth and development, and disease later in life.  
Environmental signals can be transmitted from the mother to the fetus, impacting 
specific vulnerable tissues in their sensitive developmental stage, modulating normal 
development trajectory, remodeling their structure and function and reprogramming the 
resiliency or susceptibility to diseases in postnatal life.  
Plenty of studies, using different maternal perturbation, have demonstrated a 
significant effect on the organogenesis due to those adverse environments.  Malnutrition 
is one of the most common that may contribute to perinatal programming, and both ends 
have been extensively studied, from undernutrition (caloric and protein restriction diets or 
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low-vitamin intake) (Erkkola, Nwaru, & Viljakainen, 2011; Mackay, Khazall, Patterson, 
Wellman, & Abizaid, 2013; Woods, Ingelfinger, Nyengaard, & Rasch, 2001) to 
overnutrition (high-fat, high-energy and high-protein diets) (Elahi et al., 2009; Gniuli et 
al., 2008; Oster, Murani, Metges, Ponsuksili, & Wimmers, 2012). Another environmental 
stress for fetal development is maternal smoking. It is estimated that approximately 22% 
of pregnant mothers smoke during the gestational period (Nelson & Taylor, 2001).  The 
use of nicotine during pregnancy has been reported to affect the organogenesis of the 
brain (Bruin, Gerstein, & Holloway, 2010) and the heart (Xiao, Huang, Yang, & Zhang, 
2011) and eventually it affects the function of these organs during adulthood.  Brain and 
cardiovascular programming diseases also occurred when the fetus is exposed to cocaine 
(Gressens, Mesples, Sahir, Marret, & Sola, 2001; Xiao, Huang, Xu, Yang, & Zhang, 
2009). Plenty of evidence has demonstrated that fetal stress induces an abnormal 
development of organs and could program them to be more vulnerable to some kind of 
disease or condition later in life.  
 
Kidney Development 
The “developmental programming of health and disease” hypothesis has been 
extended to other adult diseases as lung function, (Stein et al., 1997) learning ability 
(Strang-Karlsson et al., 2008), immune function (McDade, Beck, Kuzawa, & Adair, 
2001) and also renal function (Manalich, Reyes, Herrera, Melendi, & Fundora, 2000). 
One of the most important functions of the kidney is to filtrate urine by small structures 
called nephrons. A human kidney contains an average ~ 1 million nephrons, but the range 
in normal human population varies considerably (Hughson, Douglas-Denton, Bertram, & 
Hoy, 2006). Hypertension is one of the most common diseases associated with fetal 
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programing. It has been hypothesized that high risk for hypertension is due to a 
congenital deficiency in the number of nephrons, which results in a reduction of the 
filtration surface area that programs a subsequent reduction in glomerular filtration rate. 
This reduction in GFR will lead to an increase in sodium retention and eventually 
hypertension (Mackenzie & Brenner, 1995). Human and animal studies of low birth 
weight newborns demonstrate a reduced glomerular number. Thus, the process and 
consequence of reduced intrauterine growth is sufficient to impair renal development. 
Furthermore, a reduction in the nephron number and an increase blood pressure on the 
offspring has been reported in studies using different maternal adverse environment such 
as low protein diet (Woods et al., 2001), glucocorticoids (Ortiz, Quan, Zarzar, Weinberg, 
& Baum, 2003), placenta insufficiency (Wlodek, Westcott, Siebel, Owens, & Moritz, 
2008) and maternal sodium overload (Koleganova et al., 2011). 
In rats, the second half of gestation is a critical period for renal development 
because nephrogenesis process is during this time; being the late renal development 
period, the most susceptible due to the nephron number increasing exponentially at this 
time. Therefore, any kind of fetal adverse environment during nephrogenesis will induce 
an impairment renal development that cannot be restored later in gestation, even if the 
adverse environment is removed (O'Sullivan et al., 2013; Singh et al., 2007). 
The renin angiotensin system has been associated in certain of these program 
outcomes. It is known that RAS is often repressed during renal development, potentially 
contributing to the nephron deficit, followed by a compensatory increase in activity in 
postnatal life (Moritz et al., 2010). Given the essential function of the RAS in fluid 
balance and blood pressure control in the adult, long-term up-regulation of this system, 
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combined with the low nephron endowment, provides a highly plausible pathway through 
which prenatal insults may result in hypertension. 
 
Brain Development 
The brain is one of the critical targets of stressors and is also the central organ 
responsible for stress responses, determining the adaptive or maladaptive responsiveness 
to various acute and chronic stressful events via making corresponding alterations in its 
structure and function (McEwen, 2008). The developing brain in the fetal stage is also 
highly plastic, flexible, and especially sensitive to numerous adverse environmental 
factors. Combined with its specific genetic traits, these changes of fetal brain contribute 
to a high incidence of a wide spectrum of neurodevelopmental disorders in the postnatal 
life. It has been well documented that fetal stresses, such as hypoxia, malnutrition, 
substances exposure (nicotine, alcohol and cocaine) and excess glucocorticoids 
(endogenous or exogenous), have long lasting impact on the developing brain; altering 
brain’s ontogeny, organization, structure and function; remodeling brain’s development 
trajectory, and reprogramming brain’s vulnerability or resiliency of some 
neurobehavioral, neuropsychological and neuropsychiatric disorders later in life (Harris 
& Seckl, 2011). 
It is known that the last week of gestation for mice and rats, where fetal brain 
development is taking place, is parallel with the first-second trimester of human fetal 
development and the development of the rat brain during the first two postnatal weeks are 
parallel with the third trimester in human fetal brain (Golan & Huleihel, 2006). Animal 
studies have provided evidence linking maternal adverse environment and the increased 
incidence of neurodevelopmental disorders, neurobehavioral deficits, impaired cognitive 
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performance, and increased risk of affective disorders later in life (Y. Li et al., 2012; 
Maier, Chen, Miller, & West, 1997). 
 
Maternal Hypoxia 
Another common hostile environment associated with IUGR is maternal hypoxia, 
which is a reduced level of oxygen during pregnancy; this is one of the most significant 
challenges facing obstetric clinic practice.   There are various possible scenarios, which 
could induce a hypoxia environment to the fetus. Fetal hypoxia is very common in 
pregnant women that live at high altitude; also, unfortunately, many pregnant women 
continue to smoke during pregnancy, as was mentioned before, exposing the fetus to 
prolonged hypoxemia. Furthermore, the placenta plays a very important and critical role 
in fetal development because the placenta helps to exchange oxygen, nutrients and waste 
between the mother and the offspring, therefore, if the mother has any kind of conditions 
that could affect this process as anemia, preeclampsia, or heart and lung disease this 
could result in a diminished of pO2 that may lead the fetus to experience hypoxia. 
 Fetal hypoxia results in a decrease of amniotic fluid production and a 
redistribution of fetal blood flow away from peripheral circulation, but an increase of 
perfusion to the brain, heart and liver (Richardson & Bocking, 1998). Although this 
redistribution can lead to fetal survival, this experience of adaptation can produce an 
increased risk of some health condition in adulthood. In animal models it has been 
reported that maternal hypoxia affects the organogenesis of brain (Northington, Ferriero, 
Flock, & Martin, 2001) and heart (G. Li et al., 2003; Patterson, Chen, Xue, Xiao, & 
Zhang, 2010). In the brain, the most vulnerable regions to hypoxic insult are the cerebral 
cortex, hippocampus and sub-ventricular zone (Northington, Ferriero, Graham, 
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Traystman, & Martin, 2001). In the hippocampus it was reported that a hypoxic 
environment induced neuronal death in the CA1 and that cytosolic phospholipase A2 
activity plays and important role in the neuronal degeneration mechanism (Arai et al., 
2001). Also, inflammation could play a very important role in the mechanism associated 
with fetal brain injury due to maternal hypoxia. Recently, it was reported that chronic 
hypoxia exposure induced an increase in the lactate:pyruvate ratio and a decrease in the 
GSH:GSSG ratio, a favorable pro-oxidant state, and also that the expression levels of 
Bax, Dcl-2 and p53, which are pro-apoptotic proteins, as well as the levels of some pro-
inflammatory cytokines were increased (Guo et al., 2010). In the heart, maternal hypoxia 
induced atypical expression of important genes that results in modification of the heart 
structure and function. The expression of PKC was down-regulate, while the angiotensin 
II type 2 receptor was up-regulate in the developing heart due to maternal hypoxia, 
increasing the sensitivity to cardiac ischemic injury in the offspring (Patterson et al., 
2010; Xue, Dasgupta, Chen, & Zhang, 2011). 
 
Epigenetics 
During fetal development different events occur in a way to repress or activate 
gene transcription via epigenetic mechanisms. Epigenetic control of gene expression 
involves modification of the genome without altering the DNA sequence itself. The 
chromatin-based epigenetic is very important to ensure the correct integration of 
developmental signals at gene regulatory regions in which chromatin modifications play 
very important roles. Some of these chromatin modifications are mediated by DNA 
methylation and histone posttranslational modifications, including histone methylation, 
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acetylation, phosphorylation, ubiquitylation, sumoylation and propionylation (Jungel, 
Ospelt, & Gay, 2010; Ouvry-Patat & Schey, 2007). Animal studies have demonstrated 
the importance of epigenetic changes in mediating the effects on adult phenotype and 
physiology arising from perturbations of the developmental environment, including 
maternal diet (Lillycrop, Phillips, Jackson, Hanson, & Burdge, 2005; Waterland & Jirtle, 
2003), uterine blood flow (Pham et al., 2003), and maternal nursing behavior (Weaver et 
al., 2004).  
For example, it has been reported that a maternal low-protein diet induced a 
hypomethylation in the gene promoter region of ACE-1 in the fetal brain (Goyal, Goyal, 
Leitzke, Gheorghe, & Longo, 2010); likewise the same diet decreased the methylation 
levels of exon 110 at glucocorticoids receptor gene promoter and also affect the 
expression of DNA methyl transferase 1 resultant in an increased expression of GR in the 
offspring (Lillycrop et al., 2007). Also, it is known that PKC plays a very important role 
in cardioprotection during cardiac ischemia and reperfusion injury, however fetal stress in 
animal models such as hypoxia, nicotine or cocaine exposure resulted in a repression of 
the PKC gene in the developing heart causing an increase heart vulnerability to ischemia 
and reperfusion injuries in the offspring, suggesting a common mechanism of PKC in 
fetal programming of heart disease during adulthood (Meyer, Zhang, & Zhang, 2009; 
Patterson et al., 2010). Moreover, epigenetic regulation has been associated with 
programming of type 2 diabetes mellitus.  In a recent study, where islets were isolated 
from fetuses exposed previously to IUGR, it was demonstrated that histone acetylation in 
H3 and H4 at the proximal promoter Pdx1, which plays a critical role in the development 
of the endocrine and exocrine pancreas, was decreased (S. W. Park et al., 2008). This 
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modification affected the binding of USF1, an activator of Pdx1, and the resulting 
repression of Pdx1 transcription induced the aberrant development of the pancreas (H. Li 
et al., 2006).   
As we can see, the effects on the offspring of epigenetic changes during 
development in animals mimic aspects of human disease, for example, metabolic disease, 
cardiovascular condition, or neurobiological function, and a coherent theory for a role of 
epigenetic mechanisms in the developmental origins of later chronic disease is emerging. 
 
Hypoxic-ischemic Encephalopathy 
One of the most common causes of neonatal brain damage is hypoxic-ischemic 
encephalopathy due to a systematic asphyxia, which may occur prior, during or after birth 
(Douglas-Escobar & Weiss, 2012). Epidemiological studies have demonstrated that one 
to three per 100 live full-term babies will experience HIE, where 15%-20% of them will 
die in the post natal period and 25% will develop neurological deficits and long-term 
neurodevelopmental disabilities in later life including, mental retardation, visual motor 
dysfunction, cerebral palsy and epilepsy (Vannucci & Perlman, 1997). A neonatal animal 
model for HIE has been developed to mimic this human condition and study the 
pathophysiology of perinatal HIE which is difficult to perform in a human.  This model is 
known as the Vannucci model in which 7-day postnatal rats experienced a unilateral 
common carotid ligation followed by systemic hypoxia in 8% oxygen balanced with 
nitrogen environment (Vannucci et al., 1999). This insult produces permanent hypoxic-
ischemic brain damage limited to the cerebral hemisphere ipsilateral to the carotid artery 
occlusion. Despite the advances in the last two decades in research of cellular processes 
and molecular mechanism underlying HIE, hypothermia is the only effective treatment 
9 
for full-term newborns with mild or moderate HIE, however this treatment has some 
limitations.  The use of the HIE model in this study will help us to evaluate the effect of 
adverse fetal environment on brain programming disease and also to evaluate possible 
neuroprotective mechanisms against HIE.  
 
Glucocorticoids 
Glucocorticoids are essential for life and play a crucial role in the regulation of 
growth and development, but also are implicated in various pathogenesis. The 
glucocorticoids exert their action by binding with different affinity to two receptors, the 
glucocorticoid and the mineralcorticoid receptor. Interestingly, antagonist effects have 
been associated with the glucocorticoids, where a neuroprotective and neurodegenerative 
effect has been reported (Abraham, Harkany, Horvath, & Luiten, 2001). The 
neurodegenerative effect has been found for long-term exposure and high levels of 
glucocorticoids while the neuroprotective effect has been observed for physiological 
levels of glucocorticoids. Also, glucocorticoid receptor has been affected by IUGR, 
studies with prenatal undernutrition resulting in a decreased expression of hypothalamic 
glucocorticoid receptors in rats, increasing the risk of hypertension later in life (Perez et 
al., 2010). In addition, maternal nicotine exposure decreases the mRNA expression levels 
of hippocampal GR in the offspring (Liu et al., 2012). The neuroprotective role of the 
glucocorticoid receptors was demonstrated when adult rat brains were pretreated with 
dexamethasone, a synthetic glucocorticoid, and a reduction of infarct volume after focal 
cerebral ischemia was observed (Feng, Rhodes, & Bhatt, 2011). A better understanding 
of molecular mechanisms of neuroprotection by dexamethasone may provide a basis for 
10 
the development of newer therapeutic strategies involving corticosteroids or other novel 
compounds for the prevention and treatment of HI brain injury. 
 
Prostaglandin 
Prostaglandin D2 is the most abundant prostaglandin in the brain, a metabolite 
from arachidonic acid.   This PGD2 accumulates in the cerebrospinal fluid, where it 
induces physiologic sleep in rats and humans. Recently it was reported that PGD2 
protects neonatal mouse brain from HI injury (Taniguchi et al., 2007). Also, in-vitro 
studies using rodent neuronal cells demonstrated that dexamethasone stimulates the gene 
expression of the 26 kDa glutathione-independent L-PGDS the enzyme responsible for 
the production of prostaglandin D2 (Garcia-Fernandez et al., 2000). Recent studies 
demonstrated that PGD2 elicits its downstream effects by activating two G protein-
coupled receptors; the DP and chemoattractant receptor-homologous molecule expressed 
on Th2 cells receptors (hereafter termed DP1 and DP2) where DP1 is coupled to Gαs and 
DP2 is coupled to Gαi. Interestingly, these two receptors have divergent effects on cAMP 
production, when BW245C, a DP1 agonist, is added to hippocampal neurons a rapid 
increase in cAMP is observed inducing neuroprotection, while when DK-PGD2, a DP2 
agonist, is added a decrease in cAMP production was observed resulting in neuronal 
injury (Liang, Wu, Hand, & Andreasson, 2005). Additionally, it was demonstrated that 
the activation of ERK1/2 pathway produced neuroprotection in HC2S2 hippocampal 
neurons subjected to oxygen-glucose depravation (E. M. Park et al., 2004). Interestingly, 
ERK1/2 was the major pathway for PGD2-DP receptor-mediated protection in 
cardiomyocytes (Tokudome et al., 2009). 
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The Purpose of these Studies 
Based upon the theory of programming diseases, which established that adverse 
maternal environment during the gestational period could affect the development of the 
fetus and increase the risk to diseases or detrimental health during adulthood, we 
hypothesized that maternal hypoxia affects the organogenesis of the kidney and the brain 
and program a hypoxic ischemic encephalopathy sensitive phenotype in neonatal rat 
brain (figure 1). We began our studies by evaluating how maternal hypoxia affects the 
development of kidney in fetal and offspring rats and also determine the effect on the 
expression of angiotensin II type I (AT1R) and type 2 (AT2R) receptors (Chapter 2).  
Next, we analyzed the effect of maternal hypoxia on the brain vulnerability to hypoxic-
ischemic brain injury in neonatal rats and determine how the expression of glucocorticoid 
receptors is affected by this maternal insult. The Vannucci model described previously 
was used to mimic a hypoxic-ischemic brain injury model (Chapter 3).  Then we studied 
a possible mechanism associated with the neuroprotective role of dexamethasone against 
hypoxic-ischemic brain (Chapter 4). These studies revealed that 1) maternal hypoxia 
affects the organogenesis of the kidney and the brain, 2) maternal hypoxia increases the 
brain vulnerability of neonatal rats against HIE brain injury by repressing the expression 
of glucocorticoid receptors due to a hypermethylation on the promoter region of GR gene 
exon17 and 111, and 3) the mechanism of the neuroprotective role of dexamethasone on 
HIE brain injury is associated with the MAPK/ERK pathway, where the LPGDS/PGD 
cascade plays an important function.  
12 
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Abstract 
The present study tested the hypothesis that fetal hypoxia adversely affects kidney 
development in fetal and offspring rats and alter the expression patterns of angiotensin II 
type 1 and type 2 receptors. Time-dated pregnant rats were divided between normoxic 
and hypoxic (10.5% O2 last period of gestation) groups. Protein expression, in the pups, 
was determined using western blot. Hypoxic treatment significantly decreased body and 
kidney weight in 21-day fetuses and 7-day neonates. In 3-month-old offspring there were 
no significant differences in body and kidney weight between hypoxic and control 
animals. Fetal hypoxia had no effect on kidney AT1R density in E21 or P7, but 
significantly decreased kidney AT1R protein abundance in both male and female adults. 
In contrast, kidney AT2R density was not affected by fetal hypoxia throughout the 
developmental stages studied. The hypoxia-mediated reduction of nephron numbers was 
progressively from P7 worsened into the adulthood with females affected more than 
males. The results suggest that fetal hypoxia causes programming of aberrant kidney 
development and accelerates the aging process of the kidney during the postnatal 
development, which may contribute to an increased risk of cardiovascular disease. 
22 
Introduction 
The most critical period of the human being is during fetal development, the stage 
in which the mother could expose the fetus to adverse environment that could have a 
long-term effect during adulthood. The studies of Barker and colleagues are the 
fundament for what is known as developmental programming of diseases in which they 
found an inverse relationship between birth weight and cardiovascular diseases later in 
the adulthood (Barker, 1995, 1997). Two of the most common challenges to the fetus 
during development are reduction in oxygen and nutrient delivery. There are various 
maternal stressors that could affect body weight in the offspring, for example maternal 
protein-restriction diet (Woods, Ingelfinger, Nyengaard, & Rasch, 2001), nicotine 
exposure (Lawrence et al., 2008), intrauterine malnutrition (Zhang et al., 2000), and 
hypoxia (Julian et al., 2007).  
Retardation of renal development that occurs in individuals of low birth weight 
increases the risk of renal diseases during adulthood (Brenner & Chertow, 1994). The 
process of nephrogenesis in the rats starts during mid-gestation and finishes after post-
natal day 10 (Larsson, Aperia, & Wilton, 1980). Previous studies demonstrated that 
maternal low-protein diet in rats resulted in low birth weight, suppressed the renal renin-
angiotensin system, and reduced the number of nephrons, leading to hypertension in 
offspring (Woods & Rasch, 1998). The aging process of the kidney is associated with 
physiological and functional changes, including reduced kidney weight and glomerular 
number, and changes in the shape of glomeruli and the formation of glomerular arterioles 
(Weinstein & Anderson, 2010). These changes in combination with decrease in renal 
function lead to hypertension and other cardiovascular diseases. The RAS is associated 
with one of the mechanisms that are involved in developmental problems in fetal organs, 
23 
including the kidney (Tufro-McReddie, Romano, Harris, Ferder, & Gomez, 1995).  
Angiotensin II is the primary peptide in the system, which activates two subtypes of G-
protein coupled receptors: angiotensin II type 1 and type 2 receptors. The AT1R plays a 
key role in the regulation of blood pressure, hormone secretion and renal function while 
AT2R is involved mainly in the development and growth (de Gasparo, Catt, Inagami, 
Wright, & Unger, 2000).  
Little is known about the effect of common fetal stress of hypoxia on the kidney 
development. Therefore, in the present study, we determined the effect of fetal hypoxia 
on the glomerular development and the expression patterns of AT1R and AT2R in the 
kidney in three developmental stages of near-term fetal, neonatal, and adult rats. The 
results suggest that fetal hypoxia causes programming of aberrant kidney development 
and accelerates the aging process of the kidney during the postnatal development, which 
may contribute to an increased risk of cardiovascular disease, particularly hypertension in 
offspring.  
 
Material and Methods 
Experimental Animals and Hypoxic Exposure 
Time-dated pregnant Sprague-Dawley rats were purchased from Charles River 
Laboratories (Portage, MI) and were randomly divided into normoxic control group and 
continuous hypoxic exposure group.  The hypoxic group was exposed to 10.5% oxygen 
from day 15 to day 21 of gestation, a period comparable with the third trimester of 
gestation in humans.  Hypoxia was induced to the pregnant rats by a mixture of nitrogen 
gas and air in individual chambers as described previously (G. Li et al., 2003). The 
normoxic control group was housed identically with room air flowing through chambers. 
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Water and food were provided as desired. Some of the pregnant rats, of both groups, were 
allowed to give birth naturally, and no fetal loss in the normoxia or hypoxia groups was 
observed.  The offspring were allowed to lactation and no further treatment before 
euthanasia at postnatal day 7 and 3 month-old. The other pregnant dams were sacrificed 
on day 21 of gestation and fetuses were collected for studies.  Kidneys were isolated and 
stored at -80°C. Body and kidney weight was determined. All procedures and protocols 
used in the present study were approved by the Institutional Animal Care and Use 
Committee of Loma Linda University and followed the guidelines in the National 
Institutes of Health Guide for the Care and Use of Laboratory Animals.  
 
Immunoblotting 
Protein abundance of renal AT1R and AT2R was determined with Western blot 
analysis as reported previously (Mao et al., 2010). Briefly, kidneys were homogenized in 
an ice-cold lysis buffer (20 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 
mM EGTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride and 2 μg/ml 
aprotinin, pH 7.4). Homogenates were centrifuged at 4°C for 10 min at 14,000g, and 
supernatants aliquots were collected and stored at -80°C.  Protein concentrations were 
determined using a protein assay kit from Bio-Rad.  Samples with equal protein (40 g) 
were loaded on 7.5% sodium dodecyl sulfate polyacrylamide gel and preformed the 
electrophoresis analysis. After electrophoresis, proteins were transferred to nitrocellulose 
membranes. Nonspecific binding was blocked in TBST containing 5% dry milk for 60 
min at room temperature. The membranes were incubated with rabbit AT1R and AT2R 
polyclonal antibody (1:1000 and 1:2000 dilution respectively; Santa Cruz Biotechnology, 
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Santa Cruz, CA) overnight at 4°C. The membranes were then washed and incubated with 
secondary horseradish peroxidase-conjugated goat anti-rabbit antibody (1:4000 dilution; 
Santa Cruz Biotechnology, Santa Cruz, CA). Protein bands were visualized with 
enhanced chemiluminescence reagents, and the blots were exposed to Hyperfilm (GE 
Healthcare).  Results were analyzed and quantified by the Kodak electrophoresis 
documentation and analysis system with Kodak ID image analysis software. For 
comparison of the levels of AT1R and AT2R protein relative density between the groups, 
samples were normalized first to GAPDH values and then presented as fold values 
relative to sham-treated animals. 
 
RT-PCR 
Three month-old rat kidney RNA was isolated with TRIzol reagent (Invitrogen, 
Carlsbad, CA, USA) and subjected to reverse transcription with Superscript III First-
Strand Synthesis System (Invitrogen), following the manufacturer’s instructions.  Briefly, 
5 µg total RNA was reverse transcribed into cDNA in a 20 µl volume reaction following 
the protocol of 50°C for 50 minutes and 85°C for 5 minutes. The mRNA abundance of 
AT1aR and AT1bR was measured with real-time PCR using iQ SYBR Green Supermix 
(Bio-Rad, Hercules, CA, USA) as described previously and amplification of GAPDH was 
used as internal reference. Primers used for AT1aR mRNA: 5′-ccattcaccctgcctcag-3′ 
(forward) and 5′-acggctttgcttggttactc-3′ (reverse) and for AT1bR mRNA: 5′-
atgtctccagtcccctctca-3′ (forward) and 5′-tgacctcccatctccttttg-3′ (reverse).  Real-time PCR 
was performed in a final volume of 25 µl and each PCR reaction mixture consisted of 
500 nM of primers and iQ SYBR Green Supermix containing 0.625 unit hot-start Taq 
polymerase, 400 µM each of dATP, dCTP, dGTP, and dTTP, 100 mM KCl, 16.6 mM 
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ammonium sulfate, 40 mM Tris-HCl, 6 mM MgSO4, SYBR Green I, 20 nM fluorescing 
and stabilizers. We used the following real time-PCR protocol: 95°C for 10 minutes, 
followed by 40 cycles of 95°C for 10 seconds, annealing for 10 seconds at appropriate 
temperature depending on the primer sequence, 72°C for 10 seconds. Serial dilutions of 
the positive control were done on each plate to create a standard curve for the 
quantification.  
 
Glomerular Counting 
The number of glomeruli per kidney was determined for P7 and 3M female and 
male rats as previously described (Boubred et al., 2007).  Briefly, kidneys were removed 
and weighed. Whole kidneys were incubated in 50% hydrochloric acid for 45 min at 
37°C, the incubation time being dependent on kidney weight. Kidneys were rinsed with 
tap water and stored overnight at 4°C in a gauged flask. Following mechanical 
dissociation, tubules and glomeruli were suspended in 10 ml of distilled water. Three 0.5-
ml aliquots were obtained from each kidney homogenate and placed in a hemocytometer-
like chamber, and glomeruli were counted under microscope by two investigators who 
were unaware of the specimen origin. The three results were averaged, and then the value 
was used to determine the total number of glomeruli in the sample and therefore in the 
kidney. 
 
Statistical Analysis 
Results are expressed as mean ± standard error of mean.  Experimental number 
(n) represents fetuses and offspring from different dams. Statistical comparisons for the 
body and kidney weight, the kidney to body weight ratio, and the number of glomeruli 
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were conducted by two-way ANOVA followed by a Bonferroni test. Differences in AT1R 
or AT2R protein abundance between normoxic and hypoxic groups were compared using 
unpaired t-test analysis.  In all cases the differences were considered significant when P < 
0.05.  
 
Results 
Effect of Fetal Hypoxia on Body and Kidney Weight 
Fetal hypoxia resulted in a significant decrease in body and kidney weight in E21 
and P7 rats (Figure 1A, 1B). The kidney-to-body weight ratio was significantly higher in 
P7 rats than that in E21 rats (Figure 1C), indicating a continuous growth and maturation 
of the kidney in neonatal rats. Hypoxia treatment decreased the kidney-to-body weight 
ratio in E21 rats but increased it in P7 rats (Figure 1C). In 3M offspring, there were no 
significant differences in body and kidney weight in either males or females between the 
control and hypoxic-treated animals (Figures 1D and 1E).  The kidney-to-body weight 
ratio was not significantly different between males and females in adult offspring, but 
both were significantly decreased as compared with that in P7 neonates (Figures 1C and 
1F). Fetal hypoxia had no significant effect on the kidney-to-body weight ratio in either 
male or female adult offspring (Figure 1F).  
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Effect of Fetal Hypoxia on Renal AT1R and AT2R Protein and mRNA 
Abundance 
The protein abundance of AT1R and AT2R in the kidney was determined by 
Western blot analysis. As shown in figure 2, AT1R protein abundance in the kidney was 
not significantly different in either fetal or neonatal rats between the control and hypoxic-
treated animals. However, in adult offspring, AT1R protein abundance in the kidney was 
significantly decreased in both males (43%) and females (62%) that had exposed to 
hypoxia before birth, as compared with the control animals (Figure 2). In contrast, fetal 
hypoxia had no significant effect on AT2R protein abundance in the kidney at all three 
developmental stages examined (Figure 4) Consistent with the finding of protein 
abundance for 3M offspring, fetal hypoxia exposure caused a significant decrease in 
AT1R mRNA abundance in the kidney of both male and female (Figure 3).  Similar 
results were obtained on the ratio between kidney AT1R and AT2R where the fetal 
hypoxia decrease this ratio for male and female adult offspring (Figure 5). 
.  
Effects of Fetal Hypoxia on Glomerular Number 
Figure 4 shows the effect of fetal hypoxia on total number of glomeruli per kidney 
in neonates and adult offspring.  In P7 neonates, there was a small but significant 
decrease in kidney glomerular numbers in hypoxic-treated animals, as compared with the 
normoxic pups (Figure 6). This hypoxia-mediated reduction of nephron numbers was 
progressively worsened into the adulthood with females (52% reduction) affected more 
than males (26% reduction) (Figure 6). 
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Discussion 
There is plenty of evidence that correlates low birth weight in term gestation with 
an increased risk of cardiovascular disease during adulthood (Eriksson et al., 1999). The 
present finding that fetal hypoxia caused a significant decrease in the body weight of fetal 
and neonatal rats is consistent with the previous studies (Tapanainen et al., 1994). No 
significant difference was observed in the adult offspring between normoxia and 
hypoxia-treated animals in the present study, suggesting “catch-up” growth during 
postnatal development in hypoxia-treated animals. A number of studies have shown that 
in utero undernutrition causes fetal growth restriction and low birth weight, which is 
associated with “catch-up” growth during postnatal development (Chen, Martin-Gronert, 
Tarry-Adkins, & Ozanne, 2009; Woods, Weeks, & Rasch, 2004). These studies suggest a 
common response of decreased body weight in early developmental stage and “catch-up” 
growth in postnatal development in fetal malnutrition and fetal hypoxia models. It has 
been shown that low birth weight associated with accelerated postnatal growth is a trigger 
for development of adult disease and ultimately can affect longevity (Woods, Ingelfinger, 
& Rasch, 2005).  
In the present study, fetal hypoxia resulted in a decrease in the kidney weight in 
the fetus and neonate. However in adult offspring, the kidney weight was not 
significantly different between the control and hypoxic-treated animals in both females 
and males. Interesting, perinatal nicotine exposure affected the kidney weight not just in 
the fetus and neonate but also in female and male adult offspring (Mao et al., 2009). The 
finding that the kidney-to-body weight ratio was significantly greater in P7 rats than that 
in E21 rats indicates a continuous growth and maturation of the kidney in neonatal rats. 
This is consistent with the previous finding that the process of nephrogenesis in the rats 
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starts during mid-gestation and finishes after post-natal day 10 (Larsson et al., 1980).  
The finding that the kidney-to-body weight ratio was significantly decreased in adult rats 
as compared with that in neonatal rats is intriguing and suggests asymmetric growth and 
aging process of reduced kidney weight during the postnatal development 11. Hypoxia 
decreased the kidney-to-body weight ratio in E21 rats. It has been demonstrated that fetal 
hypoxia results in a decrease in amniotic fluid production and redistribution of fetal blood 
flow with a decrease in perfusion to the kidney and an increase of perfusion to the brain, 
heart and liver (Luzi et al., 1996). The finding of the increased kidney-to-body weight 
ratio in P7 rats in hypoxic animals suggests a compensatory growth of the kidney in 
neonates. Similar to the present finding, maternal protein restriction caused a decrease in 
the kidney-to-body weight ratio in the newborn and P1 offspring, but in P5 there was no 
difference in the ratio between the low protein diet and control groups (Woods et al., 
2004).  
Abnormal development of the kidney may affect adult cardiovascular and renal 
function.  Brenner et al. (Brenner, Garcia, & Anderson, 1988) introduced the hypothesis 
that due to a lower nephron number the surface area of filtration is smaller, leading to an 
increase in glomerular pressure and systematic hypertension. We demonstrated in the 
present study that fetal hypoxia decreased the nephron number in the offspring as early as 
P7 neonatal rats.  In figure 6 the diference observed in the number of glomeruli between 
normoxia and hypoxia groups for P7 is less than that observed in adults. It is generally 
perceived, at least in human, that the number of glomeruli does not change after birth but 
as mentioned aboved the nephrogenesis proces for rats started during mid-gestation and 
finishes after P10 whereby the maturation process still has not completed and therefore 
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the number of nephrons for normoxia group (P7) is smaller than the observed on adults. 
Altough the nephron number would not change during adulhood however the total 
glomerular volume may increase during adulthood due to fully-perfused glomeruli.  As 
the kidney matures, more glomeruli will become funcional as reflected by an increase in 
GFR.  In figure 1, there is no difference in the kidney-to-body weigth ratio for adults rat, 
eventhough the number of glomeruli is lower for the hypoxia group as demostrated in 
figure 6. This observation could be due to glomerular hypertrophy that maintain the renal 
filtration surface area, which may in turn lead to adverse effects in the kidney as a result 
of chronic glomerular hyperfiltration (Hostetter, 2003). 
There is plenty of evidence regarding the existence of a relationship between 
lower nephron number and hypertension in humans (Keller, Zimmer, Mall, Ritz, & 
Amann, 2003) and in rats (Gray, Denton, Cullen-McEwen, Bertram, & Moritz, 2010). 
Several different animal models including maternal alcohol administration and high salt 
diet during pregnancy demonstrated the reduced nephron number and increased blood 
pressure in adult offspring (Gray et al., 2010). Woods et al. reported that the maternal 
protein restriction decreased the number of nephrons in adult kidneys. Interesting, they 
found that although the degree of hypertension in male and female adult rats was similar, 
the number of nephrons in males was lower than that in females (Woods et al., 2004). In 
contrast to the findings in animal models of low protein diet and high salt diet (Woods et 
al., 2004), fetal hypoxia resulted in a greater reduction in the nephron number in female 
(52%) than male (26%) adult offspring. These findings suggest differential effects of fetal 
insults on gender-specific programming of aberrant nephron development. The finding 
that hypoxia-mediated reduction of nephron numbers was progressively worsened into 
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the adulthood is intriguing and suggests that fetal hypoxia causes programming of 
aberrant kidney development and accelerates the aging process of the kidney during the 
postnatal development, which may contribute to an increased risk of cardiovascular 
disease, particularly hypertension in offspring.  It has been shown that the aging process 
of the kidney is associated with reduced glomerular number, which contributes to an 
increased risk of hypertension and other cardiovascular diseases.  
The Renin-Angiotensin System is a key regulator of blood pressure, 
fluid/electrolyte homeostasis, and kidney development (Kobori et al., 2006; Woods et al., 
2001). A recent study demonstrated that prenatal nicotine exposure did not affect the 
expression of AT1R in rat kidneys of 14-days, 30-days and 3-month offspring, as 
compared with the control groups 21. However, the nicotine treatment decreased the 
expression of AT2R in all the three post-natal ages. Here we reported that fetal hypoxia 
decreased the mRNA and protein expression of AT1R just in adult offspring (5M) and the 
expression of AT2R was not affected by this maternal stress suggesting that different 
maternal stress could affect the organogenesis of the kidney in different manners. 
Additionally, it has been shown that maternal protein restriction diet suppresses the 
expression of renal RAS probably due to the reduced number of glomeruli per kidney, 
which is associated with the increased arterial blood pressure in the adult rats (Woods et 
al., 2001).  
It has been reported that AT1R and AT2R have a regulatory role in renal 
homodynamic and in tubular function, which is antagonist one form the other.  Due to 
this, the balance between these two receptors can determine the renal status in health and 
disease.  Although the expression of AT1R and AT2R alone is not a measure of kidney 
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function, a significant reduction of AT1R/AT2R protein density ratio in the kidney of 
adult offspring, whose mother were exposed to hypoxia during pregnancy, indicates that 
the renal function could be affected.  Also these receptors coupled with ANG I-
converting enzyme, which forms ANG II in the circulation are associated with the 
maintenance of blood pressure through renal and vascular mechanisms. Li et al (X. C. Li 
& Zhuo, 2008) demonstrated the intracellular expression of ANG II induces a significant 
increase in blood pleasure that was associated with a higher expression of sodium 
hydrogen exchange transporter that is coupled with ANG II-AT1 receptor axis. Using 
losartan, an antagonist for AT1R, Woods et al. demonstrated that AT1R played a key role 
in fetal programming of aberrant renal development and hypertension in offspring 
(Woods & Rasch, 1998). In the present study, we demonstrated that fetal hypoxia did not 
affect the expression of AT1R in E21 and P7 rats, but significantly decreased AT1R 
expression in adult offspring. Additionally, this effect is more pronounced in females 
than males. This is consistent with the finding of the greater reduction in nephron 
numbers in female than male adult offspring and suggests that the decreased AT1R in 
adult kidneys is due to reduced nephron numbers in hypoxic-treated animals. This finding 
raise the possibility of a sex-dependent effect due to maternal hypoxia on the renal AT1R 
expression might lead to sex differences on the impact of maternal hypoxia on adult 
disease. This could be evaluated in future studies. The finding that AT2R in the kidney 
was not significantly affected by fetal hypoxia in all the developmental ages examined in 
the present study suggests a predominate location of AT2R in extra-nephron tissues in the 
kidney. Indeed, Miyata et al. (Miyata, Park, Li, & Cowley, 1999) demonstrated that 
AT1R, but not AT2R,  mRNA was detected in the nephron.  
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Although AT1R plays an important role in normal kidney development (Oliverio 
et al., 1998), fetal hypoxia had no effect on AT1R in the kidney but decreased nephron 
numbers in P7 rats, suggesting other mechanisms may be involved in the hypoxia-
mediated abnormal nephron development. Possible mechanisms associated with the 
reduction of glomeruli that could be explore are the potential effects of fetal hypoxia on 
Wnt4 that is required by the metanephric mesenchyme for differentiation into nephron 
epithelia (Stark, Vainio, Vassileva, & McMahon, 1994), or fibroblast growth factor-2  
(Karavanova, Dove, Resau, & Perantoni, 1996) and transforming growth factor -2 
(Sanford et al., 1997) that are capable of inducing nephrons remain an intriguing area for 
future investigation.  Another possible mechanism to explore is to evaluate how prenatal 
hypoxia affects the expression of retinoid receptors, which mediates remodeling process 
in epithelial cells associated with nephron genesis (Batourina et al., 2001).  Additionally, 
it has been shown that hypoxia increases the expression of glucocorticoid receptors in the 
primary human renal cortex epithelial cells (Jenq, Rabb, Wahe, & Ramirez, 1996), and 
that glucocorticoids play an important role in accelerating the maturation process of the 
kidney function (Petershack, Nagaraja, & Guillery, 1999; Seckl, 2004). Furthermore, the 
previous study demonstrated that hypoxia up-regulated the expression of angiopoietin-2 
in cultured mouse kidney mesangial cells, which may have a synergistic paracrine role in 
the growth of glomerular endothelial during the development of the kidney (Yuan, Yang, 
& Woolf, 2000).  In humans, it has been shown that the aging process of the kidney 
induces changes in anatomic and function of the renal system, including reduction of 
glomerular filtration rate, segmental glomerular sclerosis, reduction in the number of 
glomeruli and a decrease in renal mass (Epstein, 1996).  These changes may result in 
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chronic kidney diseases a risk factor that eventually induced cardiac complications. Our 
results suggest that fetal hypoxia induces aberrant nephrogenesis and accelerates the 
aging process of the kidney. Additionally, the results suggest that the mechanisms other 
than the renal RAS may be involved in fetal hypoxia-mediated programming of abnormal 
kidney development. Future studies are required to further elucidate these unknown 
pathways.  
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Abstract 
Gestational hypoxia is a common stress to the fetal development and increases the 
risk of neonatal morbidity. We tested the hypothesis that fetal hypoxia results in 
heightened brain vulnerability to hypoxic-ischemic injury in neonatal rats via down-
regulation of glucocorticoid receptor in the developing brain. Time-dated pregnant rats 
were exposed to hypoxia (10.5% O2) from day 15 to 21 of gestation. Brain HI injury was 
determined in day 10 pups. Maternal hypoxia resulted in asymmetric intrauterine growth 
restriction in the fetus. The brain HI injury was significantly increased in maternal 
hypoxia-treated pups as compared with the normoxia control in both males and females. 
Activation of brain GR by intracerebroventricular administration of dexamethasone 
produced a concentration-dependent reduction of HI-induced brain injury in control pups.  
Maternal hypoxia significantly decreased GR mRNA and protein abundance in the fetal 
brain and neonatal hippocampus and abolished the dexamethasone-mediated 
neuroprotective effect in pup brains.  This was resulted from increased DNA methylation, 
decreased binding of transcription factors Egr-1 and Sp1 to GR gene exon 17 and 111 
promoters, and reduced expression of GR exon 17 and 111 mRNA variants. The results 
demonstrate that gestational hypoxia causes epigenetic repression of GR gene expression 
in the developing brain resulting in the heightened brain vulnerability to HI injury in 
neonatal rats.    
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Introduction 
Hypoxic-ischemic encephalopathy is the most common cause of brain damage 
due to systemic asphyxia, which may occur prior, during or after birth (Douglas-Escobar 
and Weiss, 2012). HIE occurs in about 2% of full-term infants and close to 60% in 
premature newborns, and causes significant mortality and lead to long-term neurologic 
sequelae, including learning disabilities, mental retardation, seizure and cerebral palsy 
(Graham et al., 2008; Kurinczuk et al., 2010). Although little is known about the 
pathogenesis of HIE, recent studies have suggested that adverse intrauterine environment 
may contribute to aberrant brain development (Tomalski and Johnson, 2010; Li et al., 
2012). Hypoxia is a common form of intrauterine stress, and the fetus may experience 
prolonged hypoxic stress under a variety of conditions, including pregnancy at high 
altitude, pregnancy with anemia, placental insufficiency, cord compression, preeclampsia, 
heart, lung and kidney disease, or with hemoglobinopathy.  Although it has been shown 
that fetal hypoxia affects normal brain development and induces neurological deficit in a 
variety of behavioral tests in offspring (Li et al., 2012), the effect of fetal hypoxia-
mediated stress on newborn brain HIE remains elusive.   
Many factors may be involved in the stress response in the developing brain. 
Among them, glucocorticoids are essential for the brain development and play a center 
role in the response to stress. The effects of glucocorticoids are mainly mediated via 
binding to glucocorticoid receptors, and GRs are highly expressed in the developing brain 
with dynamic and complicated ontogeny.  It has been demonstrated in humans and 
rodents that early life environment and events are critical in programming tissue-specific 
GR expression levels, particularly in the hippocampus (Xiong and Zhang; Weaver et al., 
2005; Weaver et al., 2007; Mueller and Bale, 2008; Oberlander et al., 2008; Turner et al., 
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2008; Turner et al., 2010; Li et al., 2012).  Both neurodegenerative and neuroprotective 
effects of glucocorticoids have been reported (Abraham et al., 2001). Glucocorticoids 
have been shown to affect the vulnerability of fetal and neonatal brains to hypoxia-
ischemia challenge; however, the results were inconsistent and dependent on 
experimental protocol, dosage, timing, animal age, strains and species (Tombaugh et al., 
1992; Kauffman et al., 1994; Tuor, 1995; Flavin, 1996; Tuor, 1997; Whitelaw and 
Thoresen, 2000). It appears that the concentration and duration of glucocorticoid 
treatment are the two key factors determining either detrimental or beneficial effects of 
glucocorticoids in the brain. Although exposure to long-term and high levels of 
glucocorticoids enhances neurotoxic effects in brain injury, physiological or slightly 
supra-physiological levels of glucocorticoids confer the brain protective effect to HIE 
challenges (Abraham et al., 2001).  Herein, we present evidence of a novel finding that 
chronic fetal hypoxia down-regulates GR expression in the developing brain resulting in 
the increased brain susceptibility to HI injury in neonatal rats, and suggest new insights 
of molecular mechanisms linking fetal hypoxia to the heightened HIE vulnerability in 
newborns. 
 
Materials and Methods 
Experimental Animals 
Pregnant Sprague Dawley rats were randomly divided into 2 groups: normoxic 
control and hypoxic treatment of 10.5% O2 from day 15 to 21 of gestation, as described 
previously (Patterson et al., 2010). Given that hypoxia decreased maternal food intake by 
approximately 40%, a group of pregnant rats were randomized to 60% of control food 
intake under the normoxic condition during the same gestational period as a pair-fed 
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control.  On day 21 of pregnancy, some rats were euthanized and fetal brains were 
isolated.  Other rats were allowed to give birth, and further studies were conducted in 10-
day-old neonatal pups of both sexes. All procedures and protocols were approved by the 
Institutional Animal Care and Use Committee of Loma Linda University and followed 
the guidelines by the National Institutes of Health Guide for the Care and Use of 
Laboratory Animals. 
 
Brain HI Treatment 
Brain HI injury was induced in P10 pups, as previously described (Li et al., 2012). 
Pups were anesthetized with 2% isoflurane and the right common carotid artery was 
ligated. After recovery for 1 hour, pups were treated with 8% O2 for 1.5 hours. To 
determine the role of GR in brain HI injury, GR agonist dexamethasone (Sigma-Aldrich) 
was injected into the right lateral ventricle prior to the HI treatment. Pups were 
anesthetized and fixed on a stereotaxic apparatus (Stoelting, Wood Dale, IL). An incision 
was made on the skull surface and bregma was exposed. Dexamethasone was injected at 
a rate of 1 l/minute with a 10 l syringe (Stoelting, Wood Dale, IL) on the right 
hemisphere following the coordinates relative to bregma: 2 mm posterior, 1.5 mm lateral 
and 3.0 mm below the skull surface (Li et al., 2012).  Saline was injected as the vehicle 
control. The injection lasted 2 minutes and the needle was kept for additional 5 minutes 
before its removal.  The incision was sutured. 
 
Measurement of Brain Infarct Size 
Forty-eight hours after the HI treatment, pups were sacrificed and brain infarct 
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size was determined as previously described (Li et al., 2012). Briefly, coronal slices of 
the brain (2 mm thick) were cut and immersed in a 2% solution of 2,3,5-
triphenyltetrazolium chloride monohydrate (Sigma-Aldrich) for 5 minutes at 37°C and 
then fixed by 10% formaldehyde overnight. Each slice was weighed, photographed 
separately and the percentage of infarction area for each slice was analyzed by Image J 
software (Version 1.40; National Institute of Health, Bethesda, MD), corrected by slice 
weight, summed for each brain, and expressed as a percentage of whole brain weight.  
 
Western Blot 
GR protein abundance was determined by Western blot (Xue et al., 2011).  
Briefly, brains were homogenized and protein concentrations in supernatants were 
determined.  Samples with equal amounts of proteins were separated by electrophoresis, 
and were probed with primary antibodies against GR or HIF 1 (Santa Cruz 
Biotechnology). Membranes were then incubated with a horseradish peroxidase-
conjugated secondary antibody, and proteins were visualized with enhanced 
chemiluminescence reagents.  The target protein abundance was normalized to actin.   
 
Real-time RT-PCR 
Total RNA was isolated and subjected to reverse transcription with Superscript III 
First-Strand Synthesis System (Invitrogen).  The abundance of GR mRNA and the 
alternate exon 1 variants was measured with real-time PCR using iQ SYBR Green 
Supermix (Bio-Rad), as described previously (Meyer et al., 2009; Xiong et al., 2012). 
Primers used were listed in Table 1.  Real-time PCR was performed in a final volume of 
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25 µl and each PCR reaction mixture consisted of 500 nM of primers and iQ SYBR 
Green Supermix containing 0.625 unit hot-start Taq polymerase, 400 µM each of dATP, 
dCTP, dGTP, and dTTP, 100 mM KCl, 16.6 mM ammonium sulfate, 40 mM Tris-HCl, 6 
mM MgSO4, SYBR Green I, 20 nM fluorescing and stabilizers. We used the following 
real time-PCR protocol: 95°C for 5 minutes, followed by 40 cycles of 95°C for 10 
seconds, annealing for 10 seconds at appropriate temperature depending on the primer 
sequence, 72°C for 10 seconds. Serial dilutions of the positive control were done on each 
plate to create a standard curve for the quantification. PCR was done in triplicate and 
threshold cycle numbers were averaged for each sample. 
 
Methylated DNA Immunopreciptation 
 MeDIP assays were performed with the MeDIP kit (Active Motif, Carlsbad, CA, 
USA), following the manufacturer’s instruction. Briefly, genomic DNA was extracted 
from tissues and sonicated to yield fragments ranging in size from 200 to 600 base pairs. 
The double strand DNA fragments were denatured at 95 C to produce single strand 
DNA, and a 5-methylcytosine (5-mC) antibody was then used to precipitate DNA 
containing 5-mC. The 5-mC enriched DNA was subjected to PCR analysis with primers 
flanking the GR promoter and the PCR products were visualized with 3% agarose gel 
stained with ethidium bromide and analyzed with ImageJ software. Two sets of primers 
flanking transcription factor binding sites SP1 and Egr-1 at exon 17 promoter and SP1 at 
exon 111 promoter were used: 5′-agcccctctgctagtgtgac-3′ (Promoter-17-F), 5′- 
tttctcttctcccaggctcc-3′ (Promoter-17-R); 5′-agtctggcgtcctttttggt-3′ (Promoter-111-F), 5′-
ccaatccaccctacaagccc-3′ (Promoter-111-R). 
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Table 1. Primer sequences for GR and GR gene first exons. 
 
 
Forward Reverse 
exon 14 AAGCAACACCGTAACACCTT 
AGAAGCAGCAGCCACTGA 
exon 15 CATGCAACTTCCTCCGAGT 
exon 17 GGAGCCTGGGAGAAGAGAAA 
exon 111 GCCGCAGAGAACTCAACAG 
exon 110 CACGCCGACTTGTTTATC TCTGCTGCTTGGAATCTG 
exon 16 ACCTGG CGG CAC GCG AGT GCAGCCACTGAGGGCGAAGA 
exon 18 GACAGTCGCCAACAGGTTAA TGAGAAGCAGCAGCCACT 
exon 19 GTCAGTGCCTGGAGCCCGAG AGCAGCCACTGAGGGCGAAG 
GR AGGTCTGAAGAGCCAAGAGTTA TGGAAGCAGTAGGTAAGGAGAT 
actin TCAGGTCATCACTATCGGCAAT ACTGTGTTGGCATAGAGGTCTT 
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Chromatin Immunoprecipitation 
 ChIP assay was performed using the Chip-IT Express Kit (Active Motif), as 
described previously.   Briefly, tissues were minced and fixed with 1% formaldehyde to 
crosslink and maintain the DNA/protein interactions. After the reactions were stopped 
with glycine, tissues were washed with PBS. Chromatin extracts were sonicated to 
produce DNA fragments between 200 and 600 base pairs. Antibody against Sp1, MeCP2 
(Active Motif), Egr-1 (Santa Cruz Biotechnology), and MBD1 (Abcam) were incubated 
with the chromatin extracts to precipitate the transcription factor/DNA complexes. 
Crosslinking was then reversed using a salt solution and proteins were digested with 
proteinase K.  The antibody-pulled chromatin extracts were subjected to PCR assay using 
two sets of primers that flank the predicted transcription factor binding sites at GR exon 
17 and exon 111 promoters, as described above in MeDIP. PCR products were visualized 
by 3% agarose Gel stained with ethidium bromide and analyzed with ImageJ software.  
 
Statistical Analysis 
Data are expressed as mean ± SEM.  Experimental number (n) represents fetuses 
and neonates from different dams. Statistical significance (P < 0.05) was determined by 
analysis of variance followed by Neuman-Keuls post hoc testing or Student's t test, where 
appropriate. 
 
Results 
Maternal Hypoxia Induced Asymmetrical Growth Restriction in the 
Fetus  
There was no significant difference in the litter size between normoxia control 
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(10.0 ± 1.6) and hypoxic (10.7 ± 0.8) groups. Maternal hypoxia resulted in a significant 
decrease in body and brain weight in E21 fetuses, but a significant increase in the brain to 
body weight ratio (Figure 1). In P10 pups, no significant differences in body and brain 
weight were observed between control and hypoxic animals, suggesting a catch-up 
growth of hypoxic neonates. 
 
Maternal Hypoxia Increased Neonatal Brain Vulnerability to HI Injury 
Maternal hypoxia significantly increased protein abundance of HIF-1α in both, 
the fetal and P10 pup brain (Figure 2), indicating hypoxia in the fetal and P10 pup brain.  
To evaluate the effect of fetal hypoxia on brain lesion vulnerability, pups from normoxic 
and hypoxic animals were induced to brain lesion by HI at P10.  Prenatal hypoxia 
significantly increased HI-induced brain infarct size in both male and female pups 
(Figure 3).  To verify that this effect was not due to decreased maternal food intake by 
hypoxia, a pair-fed study of approximately 60% maternal food intake as that observed in 
hypoxic pregnant rats was conducted.  No significant differences were observed in HI-
induced brain infarct size in P10 pups by maternal food restriction (Figure 4). 
 
Dexamethasone Reduced HI-Induced Neonatal Brain Damage 
The neuroprotective effect of dexamethasone on HI-induced neonatal brain 
damage was examined via intracerebroventricular administration of dexamethasone prior 
to the HI treatment.  Figure 5 shows a concentration-dependent neuroprotective effect of 
dexamethasone on HI-induced brain injury in both male and female pups.  
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Maternal Hypoxia Down-Regulated GR Expression in the Developing 
Brain 
The effect of maternal hypoxia on GR protein and mRNA abundance in the 
developing brain was shown in figure 6.  Maternal hypoxia resulted in a significant 
decrease in protein and mRNA abundance of GR in brains of both female and male E21 
fetuses (Figure 6A).  In P10 neonates, maternal hypoxia significantly reduced GR 
expression in the hippocampus (Figure 6B). 
 
Maternal Hypoxia Selectively Decreased GR Alternative Exon 1 
mRNA Variants 
GR gene has multiple alternative first exons that play important roles in regulating 
tissue specific expression of GR, and each exon 1 has its own promoter (Xiong and 
Zhang).  Among the multiple exon 1s, exon 14 to 111 are located in the proximal region 
ranged from about -4.2 to -1.7 Kb upstream of exon 2, and exhibit substantial promoter 
activities.  All exon 1 variants have unique splice donor sites and share a common exon 2 
splice acceptor site, encoding a common protein. To investigate the effect of fetal 
hypoxia on the levels of specific GR exon 1 transcripts, quantitative RT-PCR assays were 
carried out with primers designed to amplify specific mRNA transcripts containing GR 
exon 14 to exon 111.  As shown in figure 7A, in brains of both male and female fetuses, 
the abundance of exon 17 and 111 containing transcripts was significantly decreased by 
the hypoxic treatment.  Other GR exon 1 mRNA variants were not changed by hypoxia.  
Similar reductions of exon 17 and 111 transcripts were also demonstrated in the 
hippocampus of P10 neonates (Figure 7B). 
62 
 
63 
 
64 
 
65 
Maternal Hypoxia Increased Methylation of GR 17 and 111 Promoters 
Accumulating evidence indicates that prenatal stress may affect GR gene 
expression through epigenetic modification of promoter methylation (Mulligan et al., 
2012). The effects of maternal hypoxia on DNA methylation of GR exon 17 and 111 
promoters were determined by precipitation of methylated DNA and subsequent PCR 
analysis. Promoter methylation of GR exons 17 and 111 in the fetal brain was significantly 
increased by maternal hypoxia (Figure 8). 
 
Maternal Hypoxia Reduced Transcription Factor Binding to GR Exon 
17 and 111 Promoters 
To determine the functional significance of increased promoter methylation, the 
binding of methyl-CpG binding proteins MeCP2 and MBD1, as well as transcription 
factors Sp1 and Egr-1 to GR exon 17 and 111 promoters was determined in the fetal brain 
by ChIP assays.  As shown in figure 9, maternal hypoxia significantly increased the 
binding of MeCP2 to both GR exon 17 and 111 promoters, but had no effect on the 
binding of MBD1 to the GR promoters.  On the other hand, maternal hypoxia 
significantly decreased the binding of Egr-1 to exon 17 promoter and Sp1 to exon 111 
promoter, respectively, in the fetal brain (Figure 9). 
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Maternal Hypoxia Abrogated the Neuroprotective Effect of Dexamethasone 
The functional significance of fetal hypoxia-induced down-regulation of GR in 
the developing brain was determined by evaluating dexamethasone-mediated 
neuroprotective effect of HI-induced neonatal brain injury in the hypoxia-treated animals.  
As shown in figure 10, maternal hypoxia abolished dexamethasone-induced 
neuroprotective effect of HI-induced neonatal brain injury in both male and female pups. 
 
Discussion 
The present study demonstrates for the first time that fetal hypoxia increases the 
vulnerability of neonatal brains to hypoxic-ischemic encephalopathy in a rat model. 
Intracerebroventricular administration of a synthetic glucocorticoid dexamethasone 
protects the neonatal brain from hypoxic-ischemic brain injury, suggesting a local and 
direct neuroprotective effect of GR activation in the neonatal brain.  Fetal hypoxia 
significantly down-regulates GR expression in the developing brain and abrogates the 
GR-mediated neuroprotection in the neonatal brain.   
The finding that fetal hypoxia and asymmetrical growth restriction increased the 
vulnerability of neonatal rat brains to HI-induced injury suggests a novel mechanism in 
the understanding of pathogenesis of HIE that occurs at a significantly higher rate in 
compromised pregnancy and fetal development. The stage of brain development in P10 
neonatal rats is approximately equivalent to that in full-term human baby (Rice et al., 
1981; Towfighi et al., 1991). The approach of the Vannucci model in inducing HI injury 
in P10 rat brains provided a means of evaluating potential brain injury caused by birth 
asphyxia in full-term newborns. This model consists of unilateral common carotid artery  
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ligation followed by systemic hypoxia produced by the inhalation of 8% oxygen 
(Vannucci and Vannucci, 2005).  Although there is a large body of evidence indicating a 
close link between fetal stress and an increased risk of cardiovascular and metabolic 
syndrome, stroke, and neurobehavioral pathogenesis in adolescence and/or adulthood, 
little is known about the effect of fetal stress on the susceptibility of neonatal HIE. 
Consistent with the present finding, a recent study demonstrated that maternal nicotine 
administration resulted in the increased vulnerability of HI-induced brain injury in 
neonatal rats (Li et al., 2012).  Thus, these findings provide new insights linking fetal 
stress and pathophysiological consequences of heightened HIE in newborns. The lack of 
effect of maternal food restriction in the pair-fed study suggests a hypoxia-specific effect 
on the vulnerability of HI-induced brain injury in neonatal rats.   
Although the mechanisms underlying fetal stress-induced increase in neonate 
brain HI injury remain largely elusive, the present study demonstrated that 
intracerebroventricular administration of dexamethasone produced a concentration-
dependent decrease of HI-induced brain injury in both male and female neonatal rats, 
suggesting a neuroprotective effect of local and direct activation of GR in neonatal 
brains.  Dexamethasone is a synthetic glucocorticoid that provides protection against 
hypoxic ischemic brain damage (Tuor et al., 1997).  The present finding is consistent 
with the previous studies showing a dose-dependent inhibition of hypoxic-ischemic brain 
injury in neonatal rats by dexamethasone (Barks et al., 1991; Feng et al., 2011). More 
importantly, the present study demonstrated that fetal hypoxia abrogated the 
dexamethasone-induced neuroprotective effect in the neonatal brain, suggesting a 
possible mechanism of GR in fetal stress-mediated vulnerability of HIE in the neonate.   
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The loss of dexamethasone-mediated neuroprotection in the neonate in hypoxic 
animals is likely due to the down-regulation of GR expression in the developing brain.  
The GR activity in regulating tissue and cell function relies on a tight control of its 
expression levels. In both humans and rodents the regulation of GR levels occurs almost 
exclusively at the transcriptional level.  Early-life environmental events play a key role in 
programming of tissue GR levels (O'Donnell et al., 1994; Liu et al., 1997; Bertram et al., 
2001; Weaver et al., 2004).  In the present study, GR protein and mRNA abundance in 
fetal and neonatal brains was significantly decreased by fetal hypoxia. This is consistent 
with the previous finding that fetal hypoxia resulted in a significant decrease in GR 
expression in fetal and neonatal hearts (Xue et al., 2011).  These findings suggest that the 
down-regulation of GR may be a common response to fetal stress among tissues.  Human 
and rat GR genes show a high similarity and both have 11 untranslated exon 1s, all of 
which have unique splice donor sites and share a common exon 2 splice acceptor site, 
encoding a common protein (McCormick et al., 2000; Turner and Muller, 2005; Turner et 
al., 2006).  Similar to human GR gene, in rats, 8 of the alternate exon 1s, 14 to 111, are 
located in the proximal region upstream of exon 2, and exhibit substantial promoter 
activities (McCormick et al., 2000).  Whereas the mechanisms regulating the differential 
usage of these first exons in different tissues and individuals, and the role of the 5’ 
untranslated region in splicing of the coding exons remain poorly understood, multiple 
first exons plus modulation of alternative first exon activity by their promoters represent 
the complexity orchestrated by tissue-specific transcription factors in programming of 
GR expression patterns in a tissue-specific manner.  In the present study, we found that 
fetal hypoxia resulted in a significant decrease in expression levels of GR mRNA variants 
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containing exon 17 and 111 in fetal brains, which sustained in the hippocampus of P10 
neonatal brains. Whereas exon 17 has been shown to play an important role in regulating 
hippocampus GR expression and in “resetting” the HPA axis sensitivity resulting from 
maternal care and neonatal handling (McCormick et al., 2000; Oberlander et al., 2008), 
fetal stress-mediated modulation of exon 111 expression in regulating GR expression in 
the brain has not been reported.  Indeed, a previous study suggested that neonatal 
handling had no significant effect on the expression of exon 111 in rat hippocampus 
(McCormick et al., 2000).  Thus, the present finding of fetal hypoxia-induced down-
regulation of exon 111 demonstrates the complexity of GR exon 1s involved in stress-
specific and developmental age-specific regulation of GR expression in the developing 
brain, and suggests a novel mechanism of exon 111 in regulating brain GR expression 
patterns caused by fetal hypoxia.  
The finding that fetal hypoxia-induced brain GR down-regulation sustained in the 
P10 neonate suggests a permanent GR repression in the developing brain.  Accumulating 
evidence indicates that perinatal stress affects GR gene expression mainly through 
epigenetic mechanisms, and increased methylation of GR promoters has been associated 
with early life experiences in both humans and rats (Oberlander et al., 2008; Suderman et 
al., 2012). As important regulators of chromosome structure and gene expression, the 
methyl-CpG binding proteins, MeCP2 and MBD1 can bind to 5’ methylated cytosine of 
CpGs on DNA and suppress gene expression (Guy et al., 2011). The present study 
showed the binding of both MeCP2 and MBD1 to the promoters of GR exon 17 and 111 in 
the fetal brain, and the binding of MeCP2 was significantly increased by fetal hypoxia.  
Increased methyl-CpG binding proteins to GR promoters is likely to induce chromatin 
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remodeling that make local chromatin structure more condensed and less accessible to 
transcription factor binding (Jones et al., 1998; Nan et al., 1998; Jaenisch and Bird, 
2003).  Indeed, the present study demonstrated a significant decrease in the binding of 
Egr-1 to GR promoter 17 and Sp1 to GR promoter 111, respectively, providing a novel 
mechanism in fetal stress-induced down-regulation of GR expression in the brain at the 
molecular level.  Among the transcription factor binding sites defined on GR promoters, 
the NGFI-A (Egr-1) binding site at rat promoter 17 and equivalent human promoter 1F 
has been extensively studied in perinatal programming of GR expression and subsequent 
disease (Weaver et al., 2004).   Sp1 binding sites have also been reported to regulate GR 
gene expression (Suehiro et al., 2004).  In agreement with the present study, previous 
studies demonstrated that fetal stress resulted in heightened CpG methylation and 
decreased Egr-1 and Sp1 binding to PKC epsilon promoter, leading to down-regulation of 
PKC epsilon expression in the developing heart (Patterson et al., 2010; Lawrence et al., 
2011).  It is thus plausible that transcription factors including Egr-1 and Sp1 and their 
corresponding binding sites on specific gene promoters are common targets of epigenetic 
regulation by perinatal environments. 
The present investigation provides novel evidence that fetal hypoxia increases HI-
induced brain injury in neonatal rats, providing new insights linking fetal stress and 
pathophysiological consequences of heightened HIE in newborns.  Although it may be 
difficult to translate the present findings directly into humans, the possibility that fetal 
hypoxia may increase the risk of HIE in newborns provides a mechanistic understanding 
worthy of investigation in humans.  This is because hypoxia is one of the most important 
and clinically relevant stresses to the fetus and because HIE occurs at a significantly 
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higher rate in compromised pregnancy and fetal development.  The finding of fetal stress-
mediated epigenetic repression of GR in the developing brain provides a novel 
mechanism in the understanding of HIE at the molecular level, and may suggest new 
insights for the development of new therapeutic strategies that may be beneficial for the 
treatment of newborns with HIE. 
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Abstract 
Dexamethasone treatment on neonate rat brain has demonstrated neuroprotection 
against hypoxic-ischemic brain injury. However, very little is known about this 
neuroprotective mechanism. We examined the effect of dexamethasone on the level of 
pERK 1/2 and determined the effect of inhibition of LPGDS, DP1 receptor and 
MAPK/ERK on the expression of pERK ½ in the presence and absence of 
dexamethasone. In total, 116 ten-day old rats were used. Dexamethasone and inhibitors 
were administered through intracerebroventricular injections. Effect on the level of pERK 
1/2 expression patterns were assessed through western blotting. Prostaglandin D2 levels 
were determined by ELISA. HI brain injury volume was determined 48 hours after drug 
treatment. Dexamethasone increases the level of pERK-44 in normoxic brains effect that 
was repressed by the presence of PD-98059, an inhibitor of MAPK. Dexamethasone also 
increases the expression of LPGDS and the levels of PGD2 in the P10 rat brains. 
Inhibitors of LPGDS and DP1 receptor also repressed the effect of dexamethasone in the 
expression of pERK-44. Moreover, the neuroprotective effect of dexamethasone against 
HI-brain injury was blocked by the presence of those inhibitors. Dexamethasone up-
regulated the level of pERK-44 and the inhibition of the MAPK repressed the 
neuroprotective effect of dexamethasone suggesting that the neuroprotective mechanism 
of dexamethasone against HI brain injury is associated with the MAPK/ERK pathway, 
where LPGDS/PGD cascade plays a significant role. 
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Introduction 
Glucocorticoids are essential for life and play a crucial role in the regulation of 
growth and development. The brain is the major neural target for the action of GCs, 
where they bind to intracellular glucocorticoid and mineralocorticoid receptors in neurons 
and glia (Abraham, Harkany, Horvath, & Luiten, 2001).  GRs are highly expressed in the 
developing brain and a neuroprotective role against hypoxia-ischemic injury has been 
reported for dexamethasone a synthetic glucocorticoid (Gonzalez-Rodriguez, Xiong, Li, 
Zhou, & Zhang, 2014). The neuroprotective effects of GCs may be mediated by distinct 
mechanisms involving modulation of Ca2+ currents, enhanced synthesis of lipocortin-1 
and neurotrophic factors, and their ability to attenuate lipid peroxidation (Flower & 
Rothwell, 1994; Joels & de Kloet, 1994; Mocchetti, Spiga, Hayes, Isackson, & 
Colangelo, 1996; Young & Flamm, 1982). However, the mechanism of neuroprotection 
for dexamethasone against hypoxia ischemia in neonate rats is not well understood. The 
intracellular mitogen activated protein kinase/extracellular signal regulated kinase 
signaling pathway is used by neurotrophins, neurotransmitters, and neuropeptides to exert 
their neurotrophic and neuroprotective effects by specifically enhancing progenitor cell 
proliferation and differentiation, neuronal process growth and regeneration, neuronal 
survival, and long-term synaptic remodeling and plasticity (Chen & Manji, 2006; Huang, 
Wu, Chen, Manji, & Chen, 2003; Sweatt, 2004). 
Prostaglandin D synthase catalyzes the isomerization of PGH2, synthetized by 
cyclooxygenase (COX)-2, to produce PGD2 (Smith, Marnett, & DeWitt, 1991; Urade & 
Hayaishi, 2000). Two types of PGDS have been purified and characterized; lipocalin-
type PGDS that was previously known as the brain-type enzyme or glutathione-
independent enzyme, and the hematopoietic PGDS, also known as the spleen-type 
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enzyme or GSH-requiring enzymes (Kanaoka & Urade, 2003; A. Nagata et al., 1991). 
Lipocalin-type PGDS is a unique bi-functional protein, is the only member of the 
lipocalin family with and associated enzymatic activity: the synthesis of prostaglandin D2 
in the central nervous system, cardiovascular system and in ocular tissues among 
others(Beuckmann et al., 1996; Beuckmann et al., 2000; Eguchi et al., 1997). Moreover, 
L-PGDS is an extracellular transporter for lipophilic ligands such as retinoids and tyroids, 
retinoic acid and amyloid  peptides (Kanekiyo et al., 2007; Pervaiz & Brew, 1987; 
Tanaka et al., 1997). Recently, it has been reported that LPGDS protected against 
neuronal cell death due to oxidative stress and HIE (Fukuhara et al., 2012; Taniguchi, 
Mohri, Okabe-Arahori, Kanekiyo, et al., 2007). Prostaglandin D2 an arachidonic acid 
metabolite, is the most abundant prostaglandin in the brain,(Hertting & Seregi, 1989) 
where it regulates sleep, temperature and nociception through two distinct G protein-
coupled receptors, DP/DP1 receptor and DP2/CRTH2 (Kabashima & Narumiya, 2003; K. 
Nagata & Hirai, 2003). Although PGD2 has been associated with inflammation in 
peripheral tissues (Honda et al., 2003), and inhibition of platelet aggregation (Yun, 
Ohman, Gill, & Keiser, 1991), in-vitro and in-vivo studies have demonstrated a 
neuroprotective role for PGD2 (Liang, Wu, Hand, & Andreasson, 2005; Taniguchi, 
Mohri, Okabe-Arahori, Aritake, et al., 2007). In the present study, we examined if the 
arachidonic cascade and the MAPK/ERK pathway are part of the neuroprotective 
mechanism of glucocorticoids.  
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Material and Methods 
Experimental Animals 
Female Sprague Dawley rats with 10-day-old neonates were purchased from 
Charles River Laboratories (Portage, MI).  All rats were kept in a room maintained at 
24°C, a 12-h light/dark cycle, and provided ad libitium access to normal rat chow and 
filtered water. All procedures and protocols were approved by the Institutional Animal 
Care and Use Committee of Loma Linda University and followed the guidelines by the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals. 
To evaluate the neuroprotective mechanism of dexamethasone, inhibitors of 
LPGDS (SeCl4, Sigma), MEK1/2 (PD98059, Sigma) and the antagonist of DP1 receptor 
(MK-0524, Santa Cruz) were used in presence and absence of dexamethasone. These 
were injected into the right lateral ventricle prior to the HI treatment.  Pups were 
anesthetized and fixed on a stereotaxic apparatus (Stoeling). An incision was made on the 
skull surface and bregma exposed. Each reagent or a cocktail was injected at a rate of 
1ul/minute with a 10 ul syringe (Stoeling) on the right hemisphere following the 
coordinates relative to bregma: 2 mm posterior, 1.5 mm lateral and 3.0 mm below the 
skull surface (Li, Gonzalez, & Zhang, 2012). Saline was injected as the vehicle control.  
The injection lasted 2 minutes and the needle was kept for additional 5 minutes before its 
removal.  The incision was sutured, and the animals were allowed to recover on a 37°C 
heated blanket.  The animals were returned to their dams after recovering from 
anesthesia. Dexamethasone and SeCl4 were purchased from Sigma. 
 
Prostaglandin Quantification 
Forty-eight hours after dexamethasone was injected to the P-10 pups, 
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dexamethasone and control group were decapitated, the amount of PGs in their fresh-
frozen right hemisphere brain was determined by ELISA (Arnold, 2012), following the 
manufacturer’s instruction with slight modification. This kit is based on the conversion of 
PGD2 to a stable methoxime derivative by treatment with methoxamine hydrochloride. 
Briefly, the right hemispheres were homogenized with 50mM KH2PO4, 5mM EDTA, 43 
mM acetylsalicylic acid and pH 7.4 buffer. Homogenate were centrifuged at 13,600 g for 
5 min and supernatants stored at -80 ° C. Samples were diluted with cold acetone, 
incubated on ice for 5 min and centrifuged at 3,000 rpm for 10 min. Frozen sample were 
lyophilized.  PGD2 concentration was measured using a PGD-Methoxime EIA kit 
(Cayman Chemicals). 
 
Western Blot 
Brains were homogenized on an ice-cold lysis buffer containing 20 mM HEPES, 
10 mM KCl, 1.5 mM MgCl2, 50 mM Tris-HCl, 10 mM EDTA, 0.1% Tween-20, 0.1% b-
mercaptoethanol, 0.1 mM phenylmethylsulfonyl fluoride, 5 ug/ml leuptin and 5 ug/ml 
aprotinin, pH 7.4. Homogenates were centrifuged at 4°C for 10 min at 14,000g, and 
supernatants aliquots were collected and stored at -80°C.  Protein concentrations were 
determined using a protein assay kit from Bio-Rad.  Samples with equal protein (40 g) 
were loaded on 10% sodium dodecyl sulfate polyacrylamide gel and preformed the 
electrophoresis analysis. After electrophoresis, proteins were transferred to nitrocellulose 
membranes. Nonspecific binding was blocked in TBST containing 5% dry milk for 60 
min at room temperature. The membranes were incubated with rabbit LPGDS, DP1 
(1:200; Santa Cruz Biotechnology) and rabbit pERK1/2 (1:1000; Cell Signaling) 
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polyclonal antibody overnight at 4°C. The membranes were then washed and incubated 
with secondary horseradish peroxidase-conjugated goat anti-rabbit antibody (1:4000; 
Santa Cruz Biotechnology, Santa Cruz, CA). Protein bands were visualized with 
enhanced chemiluminescence reagents, and the blots were exposed to Hyperfilm (GE 
Healthcare).  Results were analyzed and quantified by the Kodak electrophoresis 
documentation and analysis system with Kodak ID image analysis software. For 
comparison of the levels of LPGDS, DP1 and pERK1/2 protein relative density between 
the groups, samples were normalized first to -actin values and then presented as fold 
values relative to sham-treated animals.  
 
Brain Hypoxic-Ischemic Treatment 
Functional studies were performed by inducing brain HI injury in P10 rat pups, 
using a modified Rice-Vannucci model, described previously (Gonzalez-Rodriguez et al., 
2014). Briefly, pups were anesthetized with 2% isoflurane, a small incision was made in 
the right side of the neck where the right common carotid artery was exposed and ligated 
with silk surgical suture. The incision was sutured.  After recovery for 1 hour, pups were 
treated with 8% O2 for 2 hours. Following 3 hours of recovery, on a warm pad, the pups 
were returned to their moms.  
 
Brain Infarction Measurement 
Forty-eight hours after HI treatment pups were euthanized and brain infarct size 
was determined as previously described (Gonzalez-Rodriguez et al., 2014). Briefly, brain 
coronal slices of 2-mm thick were immersed in a 2% solution of 2,3,5-
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triphenyltetrazolium chloride monohydrate (Sigma-Aldrich) for 5 min at 37 °C and then 
fixed by 10% formaldehyde overnight. Each slice was weighed, photographed separately 
and the percentage of infarction area for each slice was analyzed by Image J software 
(Version 1.40; National Institute of Health, Bethesda, MD), corrected by slice weight, 
summed for each brain, and expressed as a percentage of whole brain weight. 
 
Statistical Analysis 
Data are expressed as mean ± SEM. Experimental number (n) represents neonates 
from different dams. Data was analyzed by Student’s t-test using GraphPad Prism 
(v5.0a). Values of P < 0.05 were considered as significant. 
 
Results 
Brain Protein Levels of pERK 1/2 Affected by Dexamethasone Treatment 
To analyze the cell signaling pathway responsible for dexamethasone 
neuroprotection, we prepared Western blots with tissue samples form P10 rat brain. 
Dexamethasone treatment on P10 rat showed a significant increase of the expression of 
pERK-44 (*p<0.05 versus saline; Figure 1) on the brain, while there was no effect of the 
dexamethasone treatment on the expression of isoform pERK-42 (*p>0.05 versus saline; 
Figure 1A).  To demonstrate that the effect on the expression of pERK-44 was associated 
with dexamethasone treatment, inhibition of MEKK with PD98059 was evaluated.  P10 
rats treated with PD98059 showed no effect on the protein expression of pERK-44 after 
dexamethasone treatment (*p>0.05 versus PD98059; Figure 1B).  
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Prostaglandin D2 Level was Increased by Dexamethasone 
We quantified the level of prostaglandin D2 in the brain of P10 rats 48 h after 
dexamethasone treatment. The level of PGD2 was significantly increased (*p<0.05 
versus control; Figure 2) by the presence of the glucocorticoid.  The level of LPGDS was 
also determined in the presence of dexamethasone. As shown in Fig. 3 the protein 
expression of LPGDS was significantly increased (*p<0.05 versus control) 48 h after 
dexamethasone treatment. Figure 4 shows western blot analysis of DP1 receptor on 
neonate brains after the dexamethasone treatment. No significant difference was observed 
(p>0.05 versus control). 
 
Inhibition of LPGDS and the Effect of Dexamethasone on pERK ½ 
We examined the effect of dexamethasone on P10 brain rats treated with SeCl4, a 
selective inhibitor of LPGDS, in the presence and absence of dexamethasone.  The 
quantitative analysis of the Western blot is shown in Figure 5A where the expression of 
pERK 1/2 is not affected by the presence of dexamethasone (p>0.05 versus SeCl4) when 
LPGDS is inhibited by selenium chloride.   
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Blocking of DP1 Receptors and the Effect of Dexamethasone on 
Protein Level of pERK½ 
The possible role of prostaglandin D2 in the neuroprotective mechanism of 
dexamethasone was evaluated by treatment of MK-0524, a DP1-selective antagonist, in 
the presence and absence of dexamethasone in P10 rat brain. Figure 5B shows that the 
protein levels of pERK 1/2 were not affected by the presence of dexamethasone (p>0.05 
versus MK-0524). 
 
Dexamethasone’s Neuroprotective Role In Vivo is Associated with 
pERK Pathway 
The HI brain injury model was used to evaluate the neuroprotective pathway 
associated with dexamethasone treatment. We applied signal transduction inhibitor 
PD98059 into intracerebroventricular space in the presence and absence of 
dexamethasone. Figure 6A shows the neuroprotective effect of dexamethasone on the 
brain exposed to HI brain injury, 4.56±0.65 (Figure 6Aii) versus 10.95±1.46 (Figure 6Ai) 
% infarction (*p<0.05), this neuroprotective effect was repressed by the presence of the 
MEKK inhibitor, 16.77±3.00 (Figure 6Aiv) versus 18.47±3.03 (Figure 6 Aiii) % 
infarction.  Treatment of the inhibitor of LPGDS in the neonate brains reversed the 
neuroprotective effect of dexamethasone, 16.38±1.70 (Figure 6Avi) versus 15.10±2.25 
(Figure 6Av) % infarction. Similar results were observed when the brains were treated 
with the DP1 antagonist, MK-0524 where dexamethasone could not protect against the 
HI brain injury, in the presence of the antagonist (18.36±1.34 versus 18.32±0.42 % 
infarction, Figure 6Avii and Figure 6Aviii). 
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Discussion 
The new findings of the present study are: (1) dexamethasone increases 
selectively the expression of the isoform of pERK-44 on P-10 neonate brains, (2) the 
interaction of arachidonic acid cascade in the neuroprotective mechanism of 
dexamethasone and (3) the neuroprotective role of dexamethasone against HI brain injury 
is associated with the MAPK/ERK pathway. 
Previous studies have demonstrated that maternal hypoxia increase the 
vulnerability of the brain to HI injury by repressing the expression of glucocorticoid 
receptor. Also, that activation of GRs by dexamethasone reduced the HI-induced brain 
injury suggesting a neuroprotective role to GRs (Gonzalez-Rodriguez et al., 2014). 
However, the neuroprotective mechanism associated with GRs is not well understood. In 
this study we reported that dexamethasone treatment increased the protein expression of 
pERK-44, although the same treatment did not affect the expression of pERK-42, 
suggesting a selective regulation of pERK-44 by dexamethasone. In vitro studies, where 
morphine down-regulated selectively pERK-42 levels with no effect on pERK-44, have 
also demonstrated a selective regulation on pERK1/2 (Muller & Unterwald, 2004). 
Neonate brains treated with PD98059 repressed the effect of the up-regulation by 
dexamethasone, suggesting that pERK-44 could be the isoform of pERK that could 
regulate the neuroprotective mechanism of dexamethasone.  The downstream part of the 
mechanism by which dexamethasone exerts this protective effect is associated with the 
blocking of the cascade of events culminating in apoptosis (Ekert et al., 1997). One 
pathway could include the phosphorylation of Thr125 in caspase-9, a conserved MAPK 
consensus site targeted by ERK2 in vitro, block the caspase-9 processing and subsequent 
caspase-3 activation (Allan et al., 2003).  
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Lipocalin-type prostaglandin D synthase catalyzes the isomerization of PGH2, a 
common precursor of various prostanoids, to produce PGD2, a potent endogenous 
somnogen and nociceptive modulator. This enzyme is the most abundant cerebrospinal 
fluid protein produced in the brain (Kanekiyo et al., 2007). LPGDS-deficient mice 
exhibited an exacerbated phenotype following transient or permanent ischemic brain 
injury, indicating a critical role of L-PGDS in protection against cerebral ischemia 
(Saleem, Shah, Urade, & Dore, 2009). HIE neonatal brains from human and mouse, 
expressed a higher number of L-PGDS-positive cells than in non-HIE neonatal brains, 
which were immunoreactive for p53, while some of these expressed cleaved caspase-3 
(Taniguchi, Mohri, Okabe-Arahori, Kanekiyo, et al., 2007). It has been demonstrated the 
neuroprotective role of PGD2 in vitro (Liang et al., 2005), therefore, it is possible that 
LPGDS may protect the neurons by local secretion of PGD2 in HIE brain. Also, 
dexamethasone treatment, in mouse neuronal cells, induces LPGDS mRNA and protein 
expression (Garcia-Fernandez et al., 2000). In our results dexamethasone treatment 
increased the protein levels of LPGDS in neonatal normoxic brains. To evaluate the 
possible role of LPGDS in the neuroprotective mechanism of dexamethasone neonate 
brains were treated with selenium chloride, and inhibitor for LPGDS, in the presence and 
absence of dexamethasone. Our data demonstrated that the effect of dexamethasone on 
the expression of pERK 44 was blocked by the presence of the LPGDS inhibitor and also 
that the neuroprotective effect of dexamethasone on HI brain injury was repressed by 
SeCl4. This data suggest that LPGDS plays a significant role on the neuroprotective 
mechanism of dexamethasone toward HI brain injury that includes the activation of the 
MAPK/ERK pathway. 
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Prostaglandins are up regulated in the ischemic brains (Nogawa, Zhang, Ross, & 
Iadecola, 1997) and it has been reported that in mouse PGD2 protects the brain from 
hypoxic ischemic injury (Taniguchi, Mohri, Okabe-Arahori, Aritake, et al., 2007). Also 
an in-vitro study demonstrated that prostaglandin D2 activated the ERK mitogen-
activated protein kinase (Choi et al., 2011). The results from our ELISA study showed 
that the levels of prostaglandin D2 increased due to the presence of glucocorticoids. 
Moreover, in our functional studies, brain treated with the DP1 antagonist, MK-0524, 
demonstrated that the neuroprotective effect of dexamethasone was blocked and at 
molecular levels dexamethasone has none effect in the expression of pERK 1/2.  Our 
results suggested that dexamethasone increased the level of prostaglandin D2 that 
eventually induced neuroprotection through the DP1 receptor by activating the 
downstream kinase ERK 1/2 which is involved in the PGD2-DP-mediated 
neuroprotection. Interestingly, it has been reported that PGD2 exerted cardioprotective 
effect by binding to the DP receptor being ERK 1/2, the major downstream pathway, due 
to the presence of glucocorticoids (Tokudome et al., 2009). 
Perinatal HI is a major cause of death and disability worldwide which has been 
limited to supportive intensive care. Although there are advances in research of cellular 
processes and molecular mechanism, hypothermia is the only treatment effective in 
neonatal HIE at present. The combination of hypothermia with neuroprotective 
treatments looks to be promising in a way to improve the neurological outcome of HI. In 
this study we demonstrated that the neuroprotective effect of dexamethasone on neonate 
HI brain injury is associated with the pathway of MAPK/ERK and that LPGDS/PGD 
cascade plays a significant role in this glucocorticoid neuroprotective mechanism. Future 
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studies related to the selective regulation of dexamethasone on the production of pERK44 
needs to be done and the possibility that pERK44 could play a neuroprotective role needs 
to be elucidated. The downstream neuroprotective mechanism of glucocorticoids, that are 
associated with apoptosis, seems like a very fertile area that could be explored to find a 
novel treatment against neonates HI brain injury. 
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CHAPTER FIVE 
GENERAL DISCUSSION 
 
Certainly the habits generated by humans such as consuming healthy food, having 
a good exercise routine, smoking, or drinking induces a clear influence in an excellent or 
detrimental health life. However the environmental area can also play a significant role. 
One environmental area that has generated more interest is the environment to which the 
fetus is exposed to during development and how the fetus has to adapt to that 
environment that can compromise the development of some organs and ultimately 
increase the risk to certain conditions or diseases during adulthood. This interest began 
with the study presented by Barker, who shows that birth weight is inversely proportional 
to the risk of cardiovascular disease and hypertension in adulthood. This was the 
foundation for what is known today as the theory of developmental of health and disease 
(Barker, 2007). Different studies have been supporting this theory, where birth weight 
has a strong correlation with risk of developing cardiovascular (Barker & Osmond, 
1986), metabolic (Hales & Ozanne, 2003), kidney, and lung (Gluckman, Hanson, Cooper, 
& Thornburg, 2008) disease among others.  This low birth weight has been associated 
with some maternal perturbation as calorie and protein restriction (Lillycrop, Phillips, 
Jackson, Hanson, & Burdge, 2005), placental insufficiency (Pham et al., 2003), exposure 
to glucocorticoids (O'Sullivan et al., 2013) that induce a harsh environment and program 
adult onset disease. Our study demonstrated that perinatal hypoxia affected the 
development of the kidney by inducing aberrant expression of angiotensin II receptors 
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and accelerating the aging process of the kidney.  Furthermore we demonstrated that 
perinatal hypoxia affected the development of the brain by increasing the vulnerability in 
neonates to hypoxic-ischemic brain injury, by repressing the expression of glucocorticoid 
receptors. 
 
Effect of Hypoxia in Kidney Development 
A hypoxia environment, on pregnant rats during their last week of pregnancy, 
affected the kidney organogenesis of the fetus. As has been mentioned, low birth weight 
is associated with programming diseases and perinatal hypoxia not just affecting the body 
weight of the E21 and P7 rats, but also affecting the kidney weight in an asymmetrical 
manner, suggesting that this adverse environment affects the development of the kidney. 
However for the 3M adult rats there was no difference between the control and the 
hypoxia treated group suggesting a “catch-up” process. Similar results were observed 
using maternal undernutrition and this acceleration during postnatal growth is a trigger 
for development of detrimental health life during adulthood (Lai et al., 2004).   
As we reported, maternal hypoxia decreases the number of nephrons, 
oligonephronia, on P7 and 3M rat offspring. It is known that any adverse event occurring 
before completion of nephrogenesis likely compromises renal growth and produces a 
longer lasting effect on final renal function (Gray, Denton, Cullen-McEwen, Bertram, & 
Moritz, 2010). The nephrons are the structure in the kidney that induces the renal 
secretory and reabsorption functions; they filter the blood and also regulate the blood 
pressure among other functions, which means that a reduction in the number of nephrons 
could be detrimental. There is a hypothesis that states that a lower number of nephrons 
will decrease the surface area of filtration and this will lead to an increase in the 
107 
glomerular pressure and eventually will induce hypertension. A reduction number of 
nephrons due to uninephroctomy during the first 24 h after birth leads to increased blood 
pressure in adult rats (Woods, 1999). Additionally, evidence using animal models has 
shown that adverse environment during pregnancy as alcohol intake or a high salt diet 
induced oligonephronia in the offspring and increased their blood pressure during 
adulthood (Gray et al., 2010; Woods, Weeks, & Rasch, 2004), suggesting this, that 
programming hypertension due to maternal hypoxia could be observed due to the 
oligonephronia found in the offspring. 
The oligonephronia observed during adulthood showed sexual dimorphism 
because, even though the effect was observed on both genders, the reduction on female 
(58%) was higher than the observed by the males (26%) suggesting that there is a gender-
specific programming in the aberrant kidney development against the females. 
Interestingly, in a study using maternal protein restriction the male exhibited 
oligonephronia, while this event was not observed in female, demonstrating a sexual 
dimorphism effect against the males (Woods, Ingelfinger, Nyengaard, & Rasch, 2001; 
Woods, Ingelfinger, & Rasch, 2005). It will be interesting to evaluate the possible effects 
of adverse environment on gender hormones that could eventually result in sexual 
dimorphism of programming diseases. For example it is known that lung maturation for 
female fetuses during fetal development is faster than in male fetuses and this difference 
is apparently due to the presence of estrogen in the females that induces stimulatory 
effects (Patrone et al., 2003). 
Otherwise, the Renin-Angiotensin System is both a circulating and tissue/organ 
specific hormonal system implicated in various physiological and pathophysiological 
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processes via the major peptide angiotensin II stimulating its specific AT1R and AT2R, 
which demonstrate opposite effects in many conditions (Dasgupta & Zhang, 2011; Sokol 
et al., 2004).  In our study we evaluate the effect of maternal hypoxia environment in the 
expression of AT1R and AT2R on the offspring. This maternal insult has no effect on the 
protein abundance of both receptors in either fetal or neonatal rats as compared with 
normoxic animals. However, there was significant difference between both groups in the 
adult offspring for the AT1R while no difference was found in the protein abundance of 
AT2R. Moreover the maternal hypoxia also decreases the mRNA abundance of AT1aR 
and AT1bR in the kidney of the offspring. Nevertheless, a study using maternal nicotine 
showed that this maternal insult has no effect on the expression of AT1R in rat kidney in 
three post-natal stages of the offspring, including adult, while the expression of AT2R 
was decreased in all three post-natal stages (Mao et al., 2009). This may suggest that 
different maternal insults affect the organogenesis of the kidney in different ways. 
Also, the RAS is of crucial importance during fetal development as angiotensin II 
acts as a potent growth factor in nephrogenesis (Woods et al., 2001). One role for 
angiotensin II during nephrogenesis is stimulating the branching of the ureteric bud by 
down-regulating the Sprouty 1 protein, which inhibits the receptor tyrosine kinase 
signaling, this effect will activate the GDNF/c-Ret/Wnt11 pathway that will eventually 
lead to the branching of the ureteric bud and eventually the formation of the nephrons 
(Yosypiv, Boh, Spera, & El-Dahr, 2008). Recently, studies suggested that maternal 
insults suppresses the renin-angiotensin system of newborns, reduced the number of 
glomeruli and leads to hypertension during adulthood (Woods et al., 2001). Our study 
demonstrated no effect of maternal hypoxia in the RAS of fetus or neonates rats, but we 
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observed an aberrant development of the kidney due to a decrease on the number of 
nephrons on neonates and adult offspring. Nephrogenesis is controlled partly by RAS but 
there are other factors that are associated with the kidney development that could be 
affected by maternal hypoxia to induce the oligonephronia observed in our work. One 
possible mechanism that could be explored is Wnt4 that is needed for the differentiation 
of the metanephric mesenchyme into nephron epithelia (Stark, Vainio, Vassileva, & 
McMahon, 1994), or evaluate the effect of maternal hypoxia on the fibroblast growth 
factor-2 (Karavanova, Dove, Resau, & Perantoni, 1996) and on the transforming growth 
factor -2 (Sanford et al., 1997), which are capable of inducing nephrogenesis.  The 
retinoid receptors might be another potential target for maternal hypoxia because they 
mediate the remodeling process of epithelial cells associated with nephrogenesis 
(Batourina et al., 2001).  
Finally, we observed that perinatal hypoxia decreased the number of glomeruli on 
offspring adult rats as compared with the normoxic group. The aging process in human 
kidney is associated with reduction of glomerular filtration rate, segmental glomerular 
sclerosis and reduction in the number of glomeruli (Epstein, 1996). Our findings not only 
suggest that perinatal adverse environment affected the kidneys in an aberrant way but 
also that this early hostile event could accelerate the kidney aging process.  
 
Effect of Hypoxia on the Vulnerability of the Brain to Neonatal 
HIE 
One of the advantages that perinatal studies offer is that they can give us some 
light of the pathogenesis of diseases and eventually lead us to develop some kind of 
treatment against those conditions. With this in mind we evaluate the effect of maternal 
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hypoxia in brain development of the rat offspring and how this insult affects the 
vulnerability of the brain against hypoxia-ischemic brain injury.  Consistent with results 
reported in our kidney studies, maternal hypoxia affected the body weight of the fetus but 
also the weight of the brain in an asymmetrical pattern. Interestingly, when we compare 
the organ/body weight ratio for the brain and kidney, the ratio observed for the kidneys, 
which were exposed to maternal hypoxia, is lower than the control group; however the 
ratio observed for the brains that were exposed to hypoxia, was higher than for those 
brains of the normoxic group.  This result may be in agreement with the concept that if 
the fetal body experiences a decrease in the level of delivered oxygen there will be a 
decrease of the amniotic fluid and a redistribution of fetal blood flow with a decrease in 
perfusion to the kidney and an increase of perfusion to the brain, heart and liver. The 
“catch-up” event was also observed in this study where the hypoxic fetus rats have a 
lower body and brain weight as compared to the normoxic fetuses but these differences 
were not observed in the P10 pups of both groups, and as mentioned before this could 
have long-term detrimental effects for the hypoxic neonates.  
 In chapter three we reported that maternal hypoxia increases the vulnerability of 
the brain toward neonatal hypoxic-ischemic encephalopathy by a mechanism that 
involved the repressing of the expression of glucocorticoid receptors. In the following 
section we will be discussing other possible mechanisms that could increase the 
vulnerability of the brain to HIE. 
 
Mechanisms That Could be Involved in Fetal Stress-Mediated 
Increase in The Susceptibility of Neonatal HIE 
The renin-angiotensin system could be a target for maternal insult where the 
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susceptibility of neonatal toward HIE is increased by reprogramming the expression 
patterns of the RAS in the brain (Mao et al., 2009). The action of the RAS is by the 
activation of AT1R and AT2R by angiotensin II, and it is known that RAS is a circulating 
and tissue/organ specific hormonal system implicated in various physiological and 
pathophysiological processes (Dasgupta & Zhang, 2011; Shi, Mao, Xu, & Zhang, 2010; 
Sokol et al., 2004). In the brain the presence of both AT1R and AT2R can be found during 
different developmental stages with different expression patterns and signaling pathways. 
The importance of RAS in the development and evolution of cerebrovascular diseases has 
been reported in clinical trials and experimental studies with mature brains. LIFE and 
MOSES are examples of clinical trials that have been shown that by blocking the RAS it 
demonstrated neuroprotection with the prevention of first of recurrent strokes in high-risk 
populations, independent of its blood pressure-lowering effect (Lindholm et al., 2002; 
Schrader et al., 2005). Anti-apoptotic, anti-inflammatory, anti-oxidant effects can be 
observed in studies with AT1R antagonist which improve cerebral perfusion, 
demonstrating vascular-dependent and -independent neuroprotection in acute stroke 
(Ando, Zhou, Macova, Imboden, & Saavedra, 2004; Dai, Funk, Herdegen, Unger, & 
Culman, 1999; Lou et al., 2004; Zhou, Ando, Macova, Dou, & Saavedra, 2005). 
Although very little is known about the role of AT2R in neurological pathophysiology, 
evidence has been found that demonstrated the beneficial effect of AT2R in a variety of 
pathologies including various neurological conditions. The neuroprotective role of AT2R 
was suggested when this receptor was up regulated in the brain, mostly in the ischemic 
area during stroke (Mogi et al., 2006), besides increased activation of AT2R may be 
responsible for some neuroprotective effects of AT1R antagonism (Li et al., 2005). In 
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vitro stimulation of AT2R promotes intense neurite outgrowth, which can be antagonized 
by PD123319 (Laflamme, Gasparo, Gallo, Payet, & Gallo-Payet, 1996). Additionally, in 
a rat model of stroke, a direct stimulation of AT2R with CPG42112 induced a 
neuroprotective effect that was beyond blood pressure regulation (McCarthy, Vinh, 
Callaway, & Widdop, 2009). The underlying mechanisms of AT2R in neuroprotection 
remain to be elucidated. Some studies indicated that it might be related to its complicated 
interaction with AT1R in apoptotic modulation, neuronal regeneration and vasodilation in 
ischemic regions following stroke (Jones, Vinh, McCarthy, Gaspari, & Widdop, 2008; 
Saavedra, Benicky, & Zhou, 2006).  
Fetal stress may also reprogram expression patterns of matrix metalloproteinase in 
the neonatal brain, which contribute to the enhanced vulnerability of HIE. MMPs belong 
to a family of zinc-dependent proteases that exert pronounced effects in the ECM 
turnover. These enzymes remodel almost all components of the matrix and play an 
essential role in cell signaling regulation, cell survival and cell death. MMPs, especially 
MMP-2, MMP-3 and MMP-9, may target the extracellular matrix of blood vessels, basal 
lamina, and tight junctions in endothelial cells, increase the permeability of the blood-
brain barrier in neuroinflammation due to hypoxia-ischemia, multiple sclerosis and CNS 
infection, which can result in cytotoxic and vasogenic edema, promote hemorrhagic 
transformation, induce apoptosis of neurons and oligodendrocytes (Cunningham, Wetzel, 
& Rosenberg, 2005; Rosenberg, 2009). However, in later stage of such pathology, MMPs 
play critical roles in tissue repair and remodeling process via inducing angiogenesis and 
neurogenesis. Growing evidence suggests that overly up-regulated activity/expression of 
MMPs, particularly MMP-2 and MMP-9, is deleterious in the acute phase of stroke. 
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Inhibition of MMPs in the acute phase may reduce the damage to BBB (Gasche, Copin, 
Sugawara, Fujimura, & Chan, 2001). There is a report indicating decreased damage to 
BBB and reduced infarct size in a focal ischemic MMP-9 knockout model (Asahi et al., 
2001). More importantly, a recent study in a neonatal rat HIE model revealed that early 
inhibition of MMPs conferred acute and long-term beneficial effects via reducing tight 
junction proteins degradation, attenuating the permeability of BBB, improving brain 
edema, and preventing brain atrophy (W. Chen et al., 2009). Fetal hypoxia reprograms 
expression patterns of MMPs in the heart and brain and increases activities/expressions of 
both MMP-2 and MMP-9 in the neonatal brain (Tong et al., 2010; Tong, Xue, Li, & 
Zhang, 2011; Tong & Zhang, 2012). Considering the evident detrimental effects of 
MMPs in the acute stroke models and other neurological pathophysiologies, it is 
plausible that altered expression patterns of MMPs by prenatal stress are other important 
mediators in programming of ischemic-sensitive phenotype and increased susceptibility 
of HIE in the neonatal brain. 
 
Epigenetic Mechanisms in Fetal Programming 
In our study we found that the expression of the glucocorticoid receptors was 
repressed due to hypermethylation in the promoter region of the GR due to maternal 
hypoxia. One of the important adaptive mechanisms that the human body could be 
evoked to react to some adverse environments is through epigenetic modification of gene 
expression patterns. The fetal developmental stage is the most critical period for the 
human being because in the uterus the fetus can be exposed to inadequate or 
inappropriate environments that could be chemical/ nutritional or non-chemical. These 
epigenetic changes could be associated with conditions or diseases during adulthood. 
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The fetus is a critical developmental stage in which different events occur in a 
way to induce repression or activation of gene transcription via epigenetic mechanisms 
(M. Chen & Zhang, 2011).  Brain-derived neurotrophic factor plays a vital role in the 
brain development. An epidemiologic study in adolescents whose mothers smoked during 
pregnancy revealed that prenatal nicotine exposure increases DNA methylation of the 
BDNF-6 exon, and this may lead to changes in the plasticity and development of the 
brain (Toledo-Rodriguez et al., 2010). A recent study evaluated the DNA methylation 
patterns of the genes coding GR, 11b-HSD2, neuronatin and reelin in hippocampus of the 
offspring rats from pregnant animals that had been treated with a deficient methyl donor 
diet. Though the behavior differences were demonstrated between MDD and the control 
groups, the DNA methylation patterns of these genes were not altered (Konycheva et al., 
2011). However, it has been shown that maternal stress of pregnant rats during 
gestational days 12–16 increases the levels of DNA methylation in frontal cortex and 
hippocampus in offspring, which is associated with behavioral changes in offspring rats 
(Mychasiuk, Ilnytskyy, Kovalchuk, Kolb, & Gibb, 2011). Additionally, it has been found 
that fetal exposure to bisphenol A (BPA), a xenoestrogen, induces changes in DNA 
methylation patterns in the 2500 Notl loci, suggesting that the maternal BPA exposure 
may also exert some programming effects on brain development (Yaoi et al., 2008).   
Recently, there has been increased interest to evaluate the effect of maternal 
environment on other epigenetic modifications that could lead to programming diseases. 
Synthetic glucocorticoids are used during pregnancy to support the maturation of fetal 
organs. Though the exposure to sGC during fetal development has resulted detrimental, 
inducing endocrine and metabolic abnormalities in animal offspring. Moreover it has 
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been reported that fetal exposure to sGC resulted in substantial differences in the 
acetylation of histone h3 lysine 9, in specific gene promoters (Crudo et al., 2013). In a rat 
model of low protein diets it was demonstrated that this maternal environment repressed 
the expression of the liver X receptor  and also decreased the acetylation of H3K9 and 
H3K14 which surrounds the transcriptional start site of Lxr. The down regulation of this 
receptor leads to impaired glucose tolerance in the offspring (Vo, Revesz, Sohi, Ma, & 
Hardy, 2013).  Maternal smoking during fetal development increases the risk of 
overweight to the offspring (Weng, Redsell, Swift, Yang, & Glazebrook, 2012). In a rat 
model, elevated levels of triglycerides were found in the circulation and liver of the 
offspring, associated with maternal nicotine. The synthesis of triglycerides is catalyzed 
by the fatty acid synthase, which was up-regulated due to maternal nicotine. The FAS is 
regulated by Lxrthe expression of this receptor was also up-regulated and associated 
with an hyperacetylation of H3K9 and H3K14 which are close to the FAS promoter (Ma, 
Nicholson, Wong, Holloway, & Hardy, 2014).  
Another fetal stress associated with histone modification is maternal caffeine 
intake. This type of insult inhibited the production of adrenal corticosterone in fetus. The 
expression of StAR, which is an enzyme associated with corticosterone production, was 
down-regulated in the rat fetal adrenal due to maternal caffeine consumption (Ping et al., 
2014). This stress also affects the histone acetylation of the SF-1 promoter, which is a 
key transcription factor for StAR. The decreased in the acetylation levels of H3K9 and 
H3K14 in the promoter region of SF-1 was associated with the down-regulation of StAR. 
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Potential Neuroprotective Mechanism Against HIE 
In chapter three we suggested a neuroprotective mechanism for glucocorticoid 
receptors against HIE. Our study implied that dexamethasone induced L-PGDS 
expression, preferentially promoted PGD2 biosynthesis in the developing brain, which 
acted as a local mediator in an autocrine and/or paracrine manner to confer protective 
effects via chiefly interaction with DP1 receptor. Another finding of that study is; that 
pERK-44 acted as the major downstream effector in dexamethasone pretreatment 
mediated neuroprotection in neonatal HI brain injury (Figure 1). Apoptosis is one of the 
cell death mechanism found on HI brain injury. It is well known that activation of 
ERK/MAPK is associated with cell survival by increasing the expression of Bcl-2, which 
repress the activity of caspase 3 resulting in a decrease of apoptosis level.  Further 
experimentation into this mechanism in our HIE model will help to increase our 
knowledge on the neuroprotection mechanism of dexamethasone. Also in this section we 
are going to discuss some other potential neuroprotective mechanisms. A possible 
neuroprotective role against HIE has been suggested for the delta opioid receptors. In a 
model of asphyxia cardiac arrest, the activation of DOR by the specific agonist [d-Ala2, 
d-Leu5] encephalin induced neuronal survival, neuroprotective effect that was reversed 
by Naltrindole, an antagonist for DOR (Gao et al., 2010). DADLE also show 
neuroprotection by inducing neuron survival in astrocytes of the hippocampal CA1 
region after global cerebral ischemia (Duan et al., 2011). During an event of HIE the 
ATP-dependent Na+-K+ pumps are impaired.  This may result in an influx of Na+ and a 
leak of K+, which is detrimental for the cell.  
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Figure 1. Proposed signaling pathway in dexamethasone pretreatment induced neuroprotection against 
neonatal hypoxic-ischemic brain injury. GR indicates glucocorticoids receptor; L-PGDS indicates 
lipocalin-type prostaglandin D synthase; PGH2 indicates prostaglandin H2; PGD2 indicates prostaglandin 
D2; DP1 indicates D prostanoid; MEK1 indicates mitogen-activated kinase/ERK kinase 1; pERK-42/44 
indicates phosphorylated extracellular signal regulated kinase 42/44; SeCl4 indicates selenium chloride, a 
selective inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS); PD98059, selective inhibitor of 
MEK1; MK-0524, a selective antagonist for prostaglandin D2 receptor (DP1); HI indicates hypoxic-
ischemic; Bcl-2 indicates B-cell lymphoma 2; p38 indicates. 
 
Bcl2 ?
p38 ?
Death
Caspase 3
118 
The activation of DOR in an anoxic model decreased the K+ leakage and also the Na+ 
influx in cortical neurons (Chao, Balboni, Lazarus, Salvadori, & Xia, 2009). Moreover, 
HIE is characterized by mitochondrial dysfunction. In a study with cultured cortical 
neurons, sodium azide inhibited the mitochondrial respiratory chain, inducing brain 
injury that was reduced by the activation of DOR. This neuroprotective effect was 
inhibited by NTI (Zhu et al., 2009). 
Another possible neuroprotective mechanism against HIE is the cannabinoid 
receptor type 1. The CB1 receptors are G protein-protein coupled receptors that could be 
located in the basal ganglia, amygdale, cerebellum, hippocampus, cerebral cortex and in 
the hypothalamus as well as in tissues from other organs (Galiegue et al., 1995). Another 
detrimental effect of HIE is the generation of nitric oxide by the nitric oxide synthase. 
The activation of CB1 in brain microglial cells of rats, inhibit the NO production (Cabral, 
Harmon, & Carlisle, 2001).  Rat brain slices were exposed to oxygen-glucose deprivation 
for 30 min that resulted in an increase of glutamate and TNF-. By the activation of CB1 
neuroprotective effect was observed, the production of glutamate and TNF- was 
inhibited, however, when an antagonist of CB1 was used the neuroprotective effect was 
diminished, suggesting that the neuroprotective effect was mediated by CB1 (Fernandez-
Lopez et al., 2006).  The activation of CB1 also reduced the infarct volume after global 
and focal cerebral ischemia and protected cultured cerebral cortical neurons that were 
exposed to hypoxia and glucose deficiency (Nagayama et al., 1999).  
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Conclusion 
The fetal development period is still the most critical experience for the human 
being. In this work we demonstrated how, during this event, maternal stress could lead to 
some aberrant organogenesis in the fetus and eventually programming the offspring to an 
increase risk of disease vulnerability. We demonstrated in this work that maternal 
hypoxia, one of the most common adverse environments experienced by fetus, affects the 
fetal growth and development of the kidney and the brain of the offspring. This IUGR 
induces low weight birth on the neonates a common effect that has been found in the 
process of programming diseases. The structure of the kidney was affected by the 
maternal insult, where a lower number of glomeruli were observed for the hypoxic 
offspring where females were more affected than the males during adulthood, resulting in 
a sex dimorphism effect. Additionally, at molecular level maternal hypoxia induced an 
aberrant development by affecting the normal expression of AT1R. These observations 
suggested that fetal hypoxia, cause an aberrant development of the kidney and accelerate 
the aging process during postnatal development that could increase the risk to 
cardiovascular diseases during adulthood.  
The brain development was also affected by this maternal insult where the 
vulnerability toward HIE was increased due to this harmful fetal environment. Moreover 
it was demonstrated that maternal hypoxia affected the expression of the glucocorticoid 
receptors for which a neuroprotective role against neonate HIE brain injury was found. 
The down-regulation of the GR was associated to a hypermethylation event observed in 
the promoter region of the GR gene, suggesting that maternal environment could affect 
the organogenesis of the brain by inducing epigenetic changes in the fetus genome. 
Finally the mechanism of the neuroprotective action of GR was evaluated, where the 
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activation of the MAPK/ERK pathway, by dexamethasone, was observed. Moreover, 
dexamethasone increases the expression of LPGDS and the levels of PDG2, where the 
inhibition of LPGDS and blockade of DP1 receptor represses the neuroprotective role of 
DEX. These results suggest that LPGDS/PGD cascade plays a significant role in the 
neuroprotective mechanism of GR. 
These novel findings provide evidence that maternal environment could affect the 
fetal development including the organogenesis of the brain and the kidney. The 
possibility that maternal hypoxia increased the risk to HIE provide a mechanistic 
understanding that could be evaluated in human. The findings that the repression of the 
GR was mediated by this fetal stress and that glucocorticoid activates the MAPK/ERK 
pathway with LPGDS/PGD cascade playing a significant role, provides a novel 
mechanism in the understanding of HIE at molecular level and suggests new insight for 
development of new therapeutic strategies against neonate HIE. 
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